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Abstract 
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) has assessed five 
manganese compounds: manganous chloride, tetrahydrate; manganous sulphate, monohydrate; 
manganous oxide; manganese chelate of amino acids, hydrate; manganese chelate of glycine, 
hydrate. The safety assessment is based on the assumption that the current maximum total contents 
of manganese authorised in feed are respected. All manganese compounds under application are 
considered safe for all animal species/categories. The mean manganese intake of the European 
population includes already the manganese from animal products and does not pose a toxicological 
concern. The effect of dietary manganese fed to animals on tissue concentrations is limited. 
Supplementation of feed with the manganese compounds under assessment would consequently not 
affect consumer exposure and is of no concern for consumer safety. All manganese compounds are 
considered as eye irritants, the manganese chelate of glycine and the manganese chelate of amino 
acids as irritants to skin and the latter one as dermal sensitiser. However, the presence of nickel in all 
additives may induce contact dermatitis. Exposure to manganese in dust of all additives and to nickel 
(except manganous chloride and manganous oxide) poses a risk to users by inhalation. The use of the 
manganese compounds under assessment in animal nutrition for all animal species is not expected to 
pose a risk to the environment. The manganese compounds under assessment are recognised as 
efficacious sources of manganese in meeting animals’ requirements. 
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Summary 
Following a request from the European Commission, the Panel on Additives and Products or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on safety and 
efficacy of manganese compounds as feed additives for all animal species: manganous chloride, 
tetrahydrate; manganous sulphate, monohydrate; manganous oxide; manganese chelate of amino 
acids, hydrate; manganese chelate of glycine, hydrate. The safety assessment is based on the 
assumption that the current maximum total contents of manganese authorised in feed are respected. 
All manganese compounds under application are considered safe for all animal species/categories. 
The mean manganese intake of the European population includes already the manganese from animal 
products and does not pose a toxicological concern. The effect of dietary manganese fed to animals 
on tissue concentrations is limited. Supplementation of feed with the manganese compounds under 
assessment would consequently not affect consumer exposure and is of no concern for consumer 
safety. 
All manganese compounds are considered as eye irritants, the manganese chelate of glycine and the 
manganese chelate of amino acids as irritants to skin and the latter one as dermal sensitiser. 
However, the presence of nickel in all additives may induce contact dermatitis. Exposure to 
manganese in dust of all additives and to nickel (except manganous chloride and manganous oxide) 
poses a risk to users by inhalation. 
The use of the manganese compounds under assessment in animal nutrition for all animal species is 
not expected to pose a risk to the environment. 
The manganese compounds under assessment are recognised as efficacious sources of manganese in 
meeting animals’ requirements. 
The FEEDAP Panel made some recommendations concerning (i) the monitoring of mercury and nickel 
in the additives; (ii) the characterisation of manganese chelates of amino acids, hydrate; (iii) the 
protection of the user; and (iv) the use of manganese-based additives in water for drinking, which is 
seen as critical to ensure compliance with the legally established maximum supply of manganese to 
animals. 
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1. Introduction  
1.1. Background and Terms of Reference1  
Regulation (EC) No 1831/20032 establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7. Article 10(2) of that Regulation also specifies that for existing 
products within the meaning of Article 10(1), an application shall be submitted in accordance with 
Article 7, at the latest 1 year before the expiry date of the authorisation given pursuant to Directive 
70/524/EEC for additives with a limited authorisation period, and within a maximum of 7 years after 
the entry into force of this Regulation for additives authorised without a time limit or pursuant to 
Directive 82/471/EEC. 
The European Commission (EC) received a request from TREAC EEIG (Trace Elements Authorisation 
Consortium European Economic Interest Grouping)
3,4
 for (i) authorisation of a new use and/or (ii) re-
evaluation of authorisation, of manganese-containing additives when used as feed additives for all 
animal species (category: Nutritional additives; functional group: compounds of trace elements). 
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application 
to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a 
feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation of an authorised 
feed additive). EFSA received directly from the applicant the technical dossier in support of this 
application. The particulars and documents in support of the application were considered valid by 
EFSA as of 30 May 2012. 
According to Article 8 of that Regulation, EFSA, after verifying the particulars and documents 
submitted by the applicant, shall undertake an assessment in order to determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety 
for the target animals, consumer, user and the environment and on the efficacy of the product 
‘Manganous chloride, tetrahydrate’, ‘Manganous sulphate, monohydrate’, ‘Manganous oxide’; 
‘Manganese chelate of amino acids, hydrate’ and ‘Manganese chelate of glycine, when used under the 
proposed conditions of use (see Section 3.1.7).5 
1.2. Additional information 
Manganese (Mn) is an abundant element which makes up about 0.1% of the Earth’s crust. It exists in 
a variety of oxidation states, Mn2+ and Mn3+ being the most biologically important. The elemental 
(metal) form of manganese does not occur naturally in the environment; however, manganese is a 
component of over 100 minerals (ATSDR, 2012). 
Manganese is an essential nutrient in humans and animals that plays a role in bone mineralisation, 
regulation of protein and energy metabolism, cellular protection from damaging free radical species 
and formation of glycosaminoglycans (Wedler, 1994). Manganese acts as both (i) a constituent of 
metalloenzymes, e.g. arginase, pyruvate carboxylase and manganese-superoxide dismutase (NRC, 
1989; Keen and Zidenberg-Cher, 1990; Wedler, 1994) and (ii) as activator of enzymes involved with 
either a catalytic or regulatory function (e.g. transferases, decarboxylases, hydrolases) (Wedler, 
1994). In its activating capacity, manganese can bind either to a substrate (such as adenosine 
triphosphate) or directly to a protein, thereby causing conformational changes (Keen and Zidenberg-
Cher, 1990). 
                                                          
1
 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003. 
2  Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in 
animal nutrition. OJ L 268, 18.10.2003, p. 29. 
3  TREAC EEIG – Trace Elements Authorisation Consortium. Avenue Louise 120, Box 13. 1050-Brussels. Belgium. This 
application involves 12 companies, which have been nominated in the text as (b1) to (b12). 
4  On 19/12/2012, the rights of TREAC EEIG were transferred to FEFANA asbl, Avenue Louise 130A-Box 1, 1050 Brussels, 
Belgium. 
5  The compound ‘Manganous carbonate’ was withdrawn from the application during the assessment. 
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The additives ‘Manganous chloride, tetrahydrate’, ‘Manganous sulphate, monohydrate’, ‘Manganous 
oxide’, ‘Manganese chelate of amino acids, hydrate’ and ‘Manganese chelate of glycine, hydrate’ had 
been authorised in the European Union (EU) under the element Manganese-Mn (E5) for all animal 
species ‘Without a time limit’ (Commission Regulation (EC) No 1334/20036 and Commission Regulation 
(EC) No 479/2006)
7
 and amendments. Following the provisions of Article 10(1) of Regulation (EC) No 
1831/2003, the compounds were included in the EU Register of Feed Additives under the category 
‘Nutritional additives’ and the functional group ‘Compounds of trace elements’.8 
The Scientific Committee on Animal Nutrition (SCAN) issued a report on the use of manganomanganic 
oxide in feedingstuffs (EC, 2002). EFSA issued an opinion on the safety of the chelated forms of iron, 
copper, manganese and zinc with synthetic feed grade glycine (EFSA, 2005) and three opinions on a 
manganese chelate of hydroxy analogue of methionine (EFSA, 2008a, 2009a, 2010a). In the frame of 
re-evaluation EFSA has delivered three opinions on manganese-based additives: manganese chelate 
of amino acids, hydrate (EFSA FEEDAP Panel, 2013a), manganous oxide (EFSA FEEDAP Panel, 2013b, 
2013c) and manganous sulphate monohydrate (EFSA FEEDAP Panel, 2013c). 
A compilation of risk assessments carried out on manganese and its compounds, including opinions 
from EFSA Panels other than the FEEDAP Panel, is in Appendix A. A list of authorisations of 
manganese compounds in the EU, other than as feed additive, is reported in Appendix B. 
2. Data and methodologies 
2.1. Data 
The present assessment is based on data submitted by the applicant in the form of a technical 
dossier9 in support of the authorisation request for the use of five manganese compounds 
(manganous chloride, tetrahydrate; manganous oxide; manganous sulphate, monohydrate; 
manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate) as feed additives. 
The technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 
1831/2003, Regulation (EC) No 429/2008 and the applicable EFSA guidance documents. 
The FEEDAP Panel used the data provided by the applicant together with data from other sources, 
such as previous risk assessments by EFSA or other expert bodies, scientific papers, other scientific 
reports and experts’ elicitation knowledge, to deliver the present output. 
EFSA commissioned the University of Gent (Belgium) to carry out a study on the biological role, 
content in feed and requirements in animal nutrition of selected trace and ultratrace elements, 
including manganese. The findings were submitted to EFSA in the form of a technical report (Van 
Paemel et al., 2010). Information from this report has been used in this opinion. 
EFSA has verified the European Union Reference Laboratory (EURL) report as it relates to the 
methods used for the control of manganese (five compounds, including: manganous chloride, 
tetrahydrate; manganous oxide; manganous sulphate, monohydrate; manganese chelate of amino 
acids, hydrate; manganese chelate of glycine, hydrate) in animal feed. The Executive Summary of the 
EURL report can be found in the Annex.10 
2.2. Methodologies 
The approach followed by the FEEDAP Panel to assess the safety and efficacy of five manganese 
compounds (manganous chloride, tetrahydrate; manganous oxide; manganous sulphate, 
monohydrate; manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate) is 
                                                          
6  Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
additives in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11. 
7  Commission Regulation (EC) No 479/2006 of 23 March 2006 as regards the authorisation of certain additives belonging to the 
group compounds of trace elements. OJ L 86, 24.3.2006, p. 4. 
8  European Union Register of Feed Additives pursuant to Regulation (EC) No 1831/2003. 
http://ec.europa.eu/food/food/animalnutrition/feedadditives/comm_register_feed_additives_1831-03.pdf 
9  FEED dossier reference: FAD-2010-0088. 
10 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/files/FinRep-SANCO-Manganese.pdf 
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in line with the principles laid down in Regulation (EC) No 429/200811 and the relevant guidance 
documents: Guidance on nutritional additives (EFSA FEEDAP Panel, 2012a), Technical guidance: 
Tolerance and efficacy studies in target animals (EFSA FEEDAP Panel, 2011), Technical Guidance for 
assessing the safety of feed additives for the environment (EFSA, 2008b), Guidance for the 
preparation of dossiers for the re-evaluation of certain additives already authorised under Directive 
70/524/EEC (EFSA, 2008c), Guidance for the preparation of dossiers for additives already authorised 
for use in food (EFSA FEEDAP Panel, 2012b), Guidance for establishing the safety of additives for the 
consumer (EFSA FEEDAP Panel, 2012c), Guidance on studies concerning the safety of use of the 
additive for users/workers (EFSA FEEDAP Panel, 2012d). 
3. Assessment 
The opinion is based on data provided by the companies joint in the application Consortium12 involved 
in the production/distribution of manganese-containing compounds, and publicly available literature. It 
should be recognised that these data cover only a fraction of the existing manganese-based additives 
placed on the market. 
The additives under assessment are: manganous chloride, tetrahydrate; manganous oxide; 
manganous sulphate, monohydrate; manganese chelate of amino acids, hydrate; manganese chelate 
of glycine, hydrate. These compounds are already authorised in the EU for use in feed. Additionally, 
some of the compounds are applied for use in water. Therefore, a re-evaluation of authorisation, or a 
new use of an additive is sought, depending on the compound (see Table 1). 
Table 1:  Details of the application sent by the European Commission 
Compound Request Matrix 
Feed Water for 
drinking 
1. Manganous chloride, tetrahydrate Re-evaluation 
New use of the additive 
X  
 X 
2. Manganous oxide Re-evaluation X  
3. Manganous sulphate, monohydrate Re-evaluation 
New use of the additive 
X  
 X 
4. Manganese chelate of amino acids, hydrate Re-evaluation X  
5. Manganese chelate of glycine, hydrate Re-evaluation 
New use of the additive 
X  
 X 
 
3.1. Characterisation13 
For compounds of trace elements, the element itself is considered the active substance. 
3.1.1. Manganous chloride, tetrahydrate14 
‘Manganous chloride, tetrahydrate’ (Chemical Abstracts Service (CAS) No 13446-34-9) has the 
chemical formula MnCl2•4H2O (molecular weight 197.91 Da; theoretical manganese content 27.73%). 
Characterisation and identity 
Manganese chloride tetrahydrate is formed by reacting elemental manganese with hydrochloric acid 
(37%). The solution is concentrated by evaporation and the resulting manganese chloride crystals are 
isolated, dried and packaged. 
                                                          
11 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No 
1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and 
the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1. 
12 At the time of submission the application represented 12 companies joint as a Consortium; during the assessment, the 
compound (manganous carbonate) represented by company b10 was withdrawn from the dossier; therefore, it has not been 
considered in the current opinion. 
13
 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003. 
14 One company involved in the application: (b6). 
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The product is a solid, pink in colour and odourless. Its solubility in water at 25°C is 723 g/L. It has a 
bulk density at 20°C of 0.800 g/cm3.15 
The additive contains by specification ≥ 27.0% manganese. The company provided analytical data of 
six batches showing a manganese content of 27‒33%.16,17 
Levels of heavy metals (Pb< 0.5 mg/kg product; Cd< 0.5 mg/kg product; Hg 0.02 mg/kg product) 
and As (< 0.05 mg/kg product)18 analysed in three batches comply with the thresholds set in Directive 
2002/32/EC for compounds of trace elements or, if not mentioned in the Directive, do not represent a 
safety concern. Dioxins and the sum of dioxins and dioxin-like polychlorinated biphenyls (PCBs) were 
analysed in three batches showing 0.09–0.31 ng WHO-PCDD/F-TEQ/kg and 0.12–0.47 ng WHO-
PCDD/F-PCB-TEQ/kg, respectively;19 these concentrations comply with those set in Directive 
2002/32/EC. The nickel content was < 15 mg/kg.20 
Particle size distribution was characterised in four batches of the product by laser diffraction;21,22 the 
percentage of particles with diameter < 50 µm ranged from 0% to 3.67%, and that of particles 
< 10 µm ranged from 0% to 0.02%. Dusting potential of the product (data from three batches, 
Stauber–Heubach method) ranged from 0.02 to 0.15 g/m3.23 
Stability and homogeneity 
Stability data are not required for inorganic compounds of trace elements. 
No experimental data on the homogeneous distribution of the additive were provided. Instead, the 
theoretical Jansen method (Jansen, 1992) was applied to estimate the homogeneity of the product in 
a premixture and in a piglet feed.24 However, this method has been developed to test the working 
accuracy of mixing equipment and it is not accepted by the FEEDAP Panel as a valid method for 
assessing the homogeneity of distribution of additives in feeds. Because of the high solubility in water 
of the compound, no further demonstration of homogeneity is deemed necessary. 
3.1.2. Manganous oxide25 
‘Manganous oxide’ (CAS No 1344-43-0) has the chemical formula MnO (molecular weight 70.94 Da; 
theoretical manganese content 77.39%). 
Characterisation and identity 
The raw materials are manganese ore and a reduction agent (coke). After selection and weighing, the 
raw materials are transferred into a rotate dryer for blending and elimination of the moisture in the 
mixture. A grinding process follows, to obtain the defined particle size, and then sieved. The sieved 
particles are taken to a dosage silo subsequently into an oven, where the calcination occurs at 
approximately 900°C. After cooling, the material goes through a final sieve; the sieved material finally 
goes to a storage silo. The material is then weighed and packed. The chemical composition of the 
product and the content of heavy metals is monitored. The plants have a Hazard Analysis Critical 
Control Points (HACCP) protocol implemented. 
The product is a solid, brown-green coloured powder, odourless. It is insoluble in water. It has a 
density of 5.4 g/cm3 and a bulk density of 1.6–1.9 g/cm3.26 
The additive contains by specification ≥ 60.0% manganese. The measured manganese content of the 
product (five batches per company) was of 60.3‒62.7%. For further details regarding characterisation 
and identity of manganous oxide, see Appendix C, Table 3. The manganese source is a mineral ore. 
                                                          
15 Technical Dossier/Section II/Annex 2-2-13. 
16 Technical Dossier/Section II/Annex 2-1-22. 
17 Technical Dossier/Supplementary Information (April 2015)/Annex_Qviii_Mn chloride 4H2O_batch to batch.pdf. 
18 Technical Dossier/Section II/Annex 2-1-40 (For heavy metals (Cd, Hg and Pb) and As). 
19 Technical Dossier/Section II/Annexes 2-1-58 (Dioxin and Sum of dioxin and Dioxin like). 
20 Technical Dossier/ Supplementary Information (April 2015)/Annex_Qii_Nickel_Mn chloride.pdf. 
21 Technical Dossier/Section II/Annex 2-2-30. 
22 Technical Dossier/ Supplementary Information (April 2015)/Annex_Qix_Mn chloride 4H2O_PSD.pdf. 
23 Technical Dossier/ Supplementary Information (April 2015)/Annex_Qix_Mn chloride 4H2O_Dusting potential.pdf. 
24 Technical Dossier/Section II/Annex 2-4-13. 
25 Two companies involved in the application: (b5) and (b7). 
26 Technical Dossier/Section II/Annexes 2-2-13 and 2-2-14. 
Manganese-E5 (five compounds) for all animal species 
 
 
 
 
www.efsa.europa.eu/efsajournal 9 EFSA Journal 2016;14(2):4395 
 
 
Data on the typical composition of manganous oxide in five batches showed, further to manganous 
oxide (78.4‒79.7%), concentrations above 1% for SiO2 (8.5‒9.2%), K2O (2.3‒2.8%), Al2O3 (2.1‒
2.3%), Fe2O3 (1.9‒2.5%) and BaO (1.5‒1.6%).
27 
Levels of heavy metals (Pb: 71–180 mg/kg product; Cd: 5.2–8.2 mg/kg product), F (90 mg/kg 
product) and As (34–44 mg/kg product), analysed in three to five batches of the product from each 
company, comply with the thresholds set in Directive 2002/32/EC for compounds of trace elements or, 
if not mentioned in the Directive, do not represent a safety concern. Levels for Hg reported in the first 
data set for company b7 (0.5–0.7 mg/kg product) appeared high (compared to other mercury 
thresholds, i.e. 0.1 mg/kg feed materials, 0.2 mg/kg mineral feed, 0.3 mg/kg CaCO3). Upon request of 
EFSA, the applicant argued that the company sourced new suppliers aiming at providing a manganese 
oxide with an improved quality; the company provided the analysis of 22 samples, performed between 
2011 and 2013, demonstrating a Hg content ≤ 0.04 mg/kg. 
In addition, the nickel content was analysed in a total of five production batches (two to three batches 
per company), revealing a content ranging from 370 to 867 mg/kg. 
Analyses of dioxins (two to four batches/company) and the sum of dioxins and dioxin-like PCBs (two 
to three batches/company) were carried out; concentrations (0.035–0.094 ng WHO-PCDD/F-TEQ/kg 
and 0.064–0.121 ng WHO-PCDD/F-PCB-TEQ/kg, respectively) comply with those set in Directive 
2002/32/EC. 
Particle size distribution was characterised in one batch from each company (by laser diffraction); 
30.4–41.5% (v/v) of the particles had a diameter of < 52.6 µm, and 13.7–23.0% (v/v) of the particles 
had a diameter of < 10.8 µm. Stauber–Heubach analysis of a single batch of the product with the 
highest fraction of particles with diameter < 50 µm indicated a dusting potential of 4.22 g/m3; 
additionally, the particle size of the dust of the product from the same company gave a result of 
40.1% of particles with diameter < 50 µm.28 
Stability and homogeneity 
Stability data are not required for inorganic compounds of trace elements. Nevertheless, company b7 
provided data on the shelf-life of the additive. Three batches were stored in closed bags at ambient 
conditions.29 The manganese content of the product, analysed by inductively coupled plasma atomic 
emission spectrometry, did not change over a period of at least 3 years, indicating that manganous 
oxide is stable. 
No experimental data on the homogeneous distribution of the additive were provided. Instead, the 
theoretical Jansen method (Jansen, 1992) was applied to estimate the homogeneity of the product in 
a broiler feed.30 However, this method has been developed to test the working accuracy of mixing 
equipment and it is not accepted by the FEEDAP Panel as a valid method for assessing the 
homogeneity of distribution of additives in feeds. 
3.1.3. Manganous sulphate, monohydrate31 
‘Manganous sulphate, monohydrate’ (CAS No 10034-96-5) has the chemical formula MnSO4·H2O 
(molecular weight 169.01g/mol; theoretical manganese content 32.48%). 
Characterisation and identity 
Two manufacturing processes were reported in the technical dossier. In one, manganous oxide is 
mixed with sulphuric acid, pressed and filtered; since precipitation occurs, the non-soluble impurities 
are removed. The crude manganous sulphate solution is obtained and purified by crystallisation. After 
dehydration and drying, the product is packed and labelled. 
In the other manufacturing process, manganous oxide is first produced from manganese dioxide by 
calcination. Sulphuric acid is added to produce manganous sulphate. The content of iron and cadmium 
                                                          
27 Technical Dossier/Supplementary Information (August 2015). 
28 Technical Dossier/Supplementary Information (April 2015)/Annex_Qiia_Mn oxide_particle_size_dust.pdf. 
29 Technical Dossier/Section II/Annex 2-4-2. 
30 Technical Dossier/Section II/Annex 2-4-14. 
31 Two companies involved in the application: (b7) and (b12). 
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is reduced by chemical and physical processes. The manganous sulphate solution is heated. The dried 
product is packed and labelled accordingly. 
The whole production is performed under HACCP protocols. 
The product is a solid, grey-pink crystalline powder, odourless. Its solubility in water at 20°C is 
762 g/L. The density is 3.25 g/cm3 and the bulk density ranged from 1.18 to 1.25 g/cm3.32 
The additive contains by specification ≥ 31.0% manganese. The measured manganese content of the 
product (four to six batches per company) was 31.4‒34.1%. For further details regarding 
characterisation and identity of manganous oxide, see Appendix C, Table 4. 
Levels of heavy metals (Pb < 0.5–33 mg/kg product; Cd 0.57–16 mg/kg product; 
Hg < 0.01-< 0.2 mg/kg product, four to six batches from three companies) and As (< 0.5–9.7 mg/kg 
product), measured in four to six batches from each company, and F (< 70 mg/kg product) measured 
in one batch from company b7, comply with the thresholds set in Directive 2002/32/EC for compounds 
of trace elements or, if not mentioned in the Directive, do not represent a safety concern. Dioxins 
(analysed in two to four batches per company) and the sum of dioxins plus dioxin-like PCBs (two to 
five batches from three companies) were 0.047–0.09 ng WHO-PCDD/F-TEQ/kg and 0.073‒0.138 ng 
WHO-PCDD/F-PCB-TEQ/kg, respectively; these concentrations comply with those set in Directive 
2002/32/EC. The nickel content was analysed in a total of seven production batches, revealing a 
content ranging from 23 to 891 mg/kg. 
Particle size distribution was characterised in one batch from each company (by laser diffraction); up 
to 6.5% (v/v) of the particles had a diameter of < 52.6 µm, and up to 1.6% of the particles had a 
diameter of < 10.8 µm. Stauber–Heubach analysis of a single batch of the product with the highest 
fraction of particles with diameter < 50 µm indicated a dusting potential of 6.9 g/m3; the particle size 
of the dust was requested but not provided. 
Stability and homogeneity 
Stability data are not required for inorganic compounds of trace elements. 
No experimental data on the homogeneous distribution of the additive were provided. Instead, the 
theoretical Jansen method (Jansen, 1992) was applied to estimate the homogeneity of the product in 
a broiler starter feed.33 However, this method has been developed to test the working accuracy of 
mixing equipment and it is not accepted by the FEEDAP Panel as a valid method for assessing the 
homogeneity of distribution of additives in feeds. Because of the high solubility in water of the 
compound, no further demonstration of homogeneity is deemed necessary. 
3.1.4. Manganese chelate of amino acids, hydrate34 
‘Manganese chelate of amino acids, hydrate’ is described by the applicant with the generic chemical 
formula Mn(x)1-3•nH2O, where x is the anion of any amino acid derived from hydrolysed soya protein, 
molecular weight not exceeding 1500 Da.35 
Characterisation and identity 
The manufacturing process starts with enzymatic hydrolysis of soybean protein (under specific pH 
conditions). The hydrolysis process is followed by chelation with a source of manganese. The slurry is 
dried and packed. The applicant confirmed that only unblended products are placed on the EU market 
by the companies participating in this application as no anticaking/carrier or other diluents are 
added.36 The applicant provided a generic process flow chart. 
                                                          
32 Technical Dossier/Section II/Annexes 2-2-16 and 2-2-17. 
33 Technical Dossier/Section II/Annex 2-4-11. 
34 Seven companies involved in the application: (b1), (b2), (b3), (b4), (b8), (b9) and (b12). During the course of the evaluation, 
the applicant notified that companies b3 and b8 are no longer defending this additive within the current application; no 
Supplementary Information was provided by those companies and therefore they were disregarded from the relevant 
assessment. 
35 Commission Regulation (EC) No 1334/2003 of 25 July 2003. 
36 Technical Dossier/Supplementary Information (April 2015)/2015-04-14_TREAC_EFSA-SIn reply_Manganese_FAD-2010-
0088.pdf. 
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The product is a solid, off-white to tan marbeled free-flowing powder, with a characteristic odour. It is 
reported to be dispersable in water. The product has a density of 1.4 g/cm3 and the bulk density 
ranges from 0.4 to 0.7 g/cm3.37 
The additive contains by specification ≥ 10.0% manganese. The manganese content of 25 batches of 
the additive (three to seven batches from each company) was 10.2–16.7%. The applicant was 
requested to provide data on the proportions of manganese chelate and any inorganic manganese. 
The applicant developed an indirect method (based on Fourier Transform Infrared (FTIR) 
spectroscopy) to estimate the binding of manganese to amino acids. The values were quantified by 
comparison with a calibration curve. The results of this in-house method, although validated, are not 
considered fully reliable but allow the conclusion that between 35% and 100% of total manganese 
occurs as chelates. 
Analytical data of nine batches (company/ies not specified) was provided showing the percentage of 
molecules with molecular weight ≤ 1500 Da. Considering all values, up to 30% of the molecules 
exceeded 1500 Da. The FEEDAP Panel notes that the specification of the applicant on the molecular 
weight of the compound ‘not exceeding 1500 Da’ is not met by analytical data, and does not comply 
with current legislation (Commission Regulation (EC) No 1334/2003). 
The applicant provided the analysis of five batches of the hydrolysate material before the addition of 
the manganese source for free and total amino acids; the lysinoalanine content was also analysed 
showing to be below 50 mg/100 g.  
Proximate analysis of a total of four batches (one batch from each of four companies) of the additive 
revealed a content of 2.9–8.9% moisture, and on an as is basis: 24.1–31.7% crude protein (nitrogen 
× 6.25), 0.0–1.4% lipids, 1.4–2.6% crude fibre and 26.4–46.4% ash; the mineral fraction consists of 
0.3–0.7% calcium, 6.8–9.7% sulphur, 0.1–2.6% sodium, 1.1–1.3% potassium and 0.2–0.4% 
phosphorus.38,39,40,41 For further details regarding characterisation and identity of manganese chelate 
of amino acids, hydrate, see Appendix C, Tables 5 and 6. 
Levels of heavy metals (Pb < 0.05–20 mg/kg and Cd < 0.1–7 mg/kg, at least one batch of the 
product from each company; Hg < 0.005– < 0.5 mg/kg, 10 batches from four companies), As (< 0.1–
1 mg/kg at least one batch from each company) and fluorine (F) (< 0.10 mg/kg, three batches from 
one company) comply with the thresholds set in Directive 2002/32/EC for compounds of trace 
elements, or, if not mentioned in the Directive, do not represent a safety concern. Dioxins (analysed 
in a total of 10 batches from the five companies) and the sum of dioxins plus dioxin-like PCBs 
(analysed in one to three batches from four companies) were 0.015–0.16 ng WHO-PCDD/F-TEQ/kg 
and 0.016–0.318 ng WHO-PCDD/F-PCB-TEQ/kg, respectively; these concentrations comply with those 
set in Directive 2002/32/EC. The nickel content was analysed in a total of seven production batches 
(at least one batch per company) revealing a content ranging from 11 to 472 mg/kg. 
The analysis of mycotoxins in seven batches of the product from five companies did not raise concern 
(aflatoxin B1 and ochratoxin A were found at a maximum concentration of 0.35 μg/kg and below 0.5 
μg/kg, respectively). In the batches stored from 1 to 40 months, the content of moulds, yeasts and 
total coliforms was below 100 CFU (colony-forming units)/g; Salmonella was absent in 25 g of the 
product. 
Particle size distribution was characterised in one to four batches per company by laser diffraction or 
sieving. The fraction of particles with diameter below 50 μm ranged from approximately 4% to 73%, 
and that below 10 μm ranged from 0% to 22.5%. Dusting potential (Stauber–Heubach method) was 
determined only in five batches of the product identified as having the highest percentage of particles 
< 50 µm, and was up to 0.88 g/m³; the manganese content of the dust was analysed in four batches 
                                                          
37 Technical Dossier/Section II/Annex 2-2-1 (b1), Annex 2-2-2 (b2), Annex 2-2-4 (b4), Annex 2-2-6 (b9) and Annex 2-2-7 (b12). 
38 Technical Dossier/Supplementary Information (April 2015)/Annex_Qxx_Mn chelate CoA_Company b1.pdf 
39 Technical Dossier/Supplementary Information (April 2015)/Annex_Qxx_Mn chelate CoA_Company b2.pdf 
40 Technical Dossier/Supplementary Information (April 2015)/Annex_Qxx_Mn chelate CoA_Company b4.pdf 
41 Technical Dossier/Supplementary Information (April 2015)/ Annex_Qxx_TREAC_Company b12_MANGANESE_Composition.pdf 
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and showed an average of 10.50% (range 9.8‒11.3%).42 Due to the small amount of dust collected, 
the particle size distribution of the dust could not be determined.43 
Stability and homogeneity 
No stability (including shelf-life) data were provided for the manganese chelate of amino acids, 
hydrate, in particular concerning the maintenance of the specific bonds of manganese in the chelates. 
The FEEDAP Panel recognises the analytical difficulties to demonstrate stability of these specific bonds 
and notes that the active substance is also unlikely to disappear in these products. 
The product was shown to be stable to microbial contamination for 1–40 months (see Characterisation 
and identity). 
Experimental data on the capacity for homogeneous distribution of the additive were provided by 
company b1. Manganese content was determined in 15 samples of a complementary feed for horses 
containing manganese chelate of amino acids, hydrate; the mean concentration was 411 mg total 
Mn/kg, the coefficient of variation (CV) was 0.97%.44 
3.1.5. Manganese chelate of glycine, hydrate45 
‘Manganese chelate of glycine, hydrate’ is derived from synthetic glycine mixed with a manganese 
salt. It has the generic formula Mn(x)1-3•nH2O, where x is the anion of glycine. 
Characterisation and identity 
To produce manganese chelate of glycine, hydrate, a manganese salt (sulphate, carbonate) or any 
other source of manganese is mixed with synthetic glycine; the raw materials could be of any source 
that complies with EU Regulations. The chelation reaction conditions are controlled and monitored. 
Then the product is dried. The applicant confirmed that only unblended solid products are placed on 
the EU market by the companies participating in this application. 
The product is a solid, odourless, beige to pink free-flowing powder. Its solubility in water is >10 g/L. 
The product has a density of 0.97 g/cm3 and the bulk density ranges from 0.79 to 0.92 kg/m3.46 
The additive contains by specification ≥ 15.0% manganese. The manganese content of 34 batches of 
the additive, at least three batches from each company, ranged from 15.8% to 27.0% – the large 
range results primarily from the different ratios of manganese to glycine. For further details regarding 
characterisation and identity of manganese chelate of glycine, hydrate, see Appendix C, Table 7. 
Additional data on 10 batches showed that the manganese content ranged from 16.2% to 22.7%, 
extractable glycine from 32.2% to 51.0%, sulphur from 9.5% to 15.2% and moisture from 0.4% to 
5.2%. The molar ratio of glycine to manganese in the different products ranged from 3.1 to 1.447 (see 
also Appendix C, Table 8). 
Levels of heavy metals (Pb < 0.5–34 mg/kg, Cd < 0.5–4 mg/kg, analysed in at least three batches per 
company; Hg < 0.5 mg/kg, three batches each from three companies) and As (<001–1 mg/kg, one to 
five batches per company) comply with the thresholds set in Directive 2002/32/EC for compounds of 
trace elements, or, if not mentioned in the Directive, do not represent a safety concern. Dioxins 
(analysed in one to five batches from each company) and the sum of dioxins plus dioxin-like PCBs 
(one to five batches from three companies) were 0.018‒0.17 ng WHO PCDD/F-TEQ/kg and 0.0298‒
0.153 ng WHO-PCDD/F-PCB-TEQ/kg, respectively; these concentrations comply with those set in 
Directive 2002/32/EC. Nickel was analysed in one or two batches per company, showing a range of 
53–501 mg/kg. 
                                                          
42 Technical Dossier/Supplementary Information (April 2015)/Annex_Qxvi_Mn AA chelate_Mn in dust.pdf. 
43 Technical Dossier/Supplementary Information (April 2015)/Annex_Qxvi_Mn AA chelate_PSD of dust.pdf. 
44 Technical Dossier/Section II/Annex 2-4-8. 
45 Four companies involved in this application: (b2), (b4), (b9) and (b11). 
46 Technical Dossier/Section II/Annex 2.2.8 (b2), Annex 2.2.9 (b4), Annex 2.2.10 (b9), Annex 2.2.11 (b11). 
47 Technical Dossier/Supplementary Information (April 2015). 
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Microbial contamination was analysed in one batch at 0, 24 and 48 h after dilution in water.48 At all 
time points studied, total aerobic count, moulds and yeasts were below 1 CFU/g, and Salmonella was 
not detected in 25 g sample of the product. 
Particle size distribution was characterised in one to three batches per company by laser diffraction. 
The products differed markedly in their particle size distribution. For one group of additives 100% of 
particles showed a diameter < 50 μm, with up to 93.5% of particles < 10 μm. The fraction < 50 μm 
in the other group of additives amounted up to approximately 11%; the fraction < 10 μm ranged from 
approximately 0.8 to 4%. Dusting potential (Stauber–Heubach method) was determined only in one 
batch of the product identified as having the highest percentage of particles < 50 µm and was 2.23 
g/m³. The particle size of the dust was analysed in one batch of the additive of company b2 showing 
53.4% of particles of diameter < 10 μm. The manganese content of the dust was not provided, 
although requested. 
Stability and homogeneity 
No stability (including shelf-life) data were provided for the manganese chelate of glycine, hydrate, in 
particular concerning the maintenance of the specific bonds of manganese in the chelate. The FEEDAP 
Panel recognises the analytical difficulties to demonstrate stability of this specific bond and notes that 
the active substance is also unlikely to disappear in these products. 
Experimental data on the capacity for homogeneous distribution of the additive were provided by 
company b11. Manganese content was determined in eight samples of a premixture containing 
manganese chelate of glycine, hydrate; the mean concentration was 35 mg total Mn/kg, indicating a 
CV of 5.7%.49 
3.1.6. Physico-chemical incompatibilities 
On the basis of current knowledge, no incompatibilities resulting from the use of manganese in 
compound feed are expected, other than those widely known and considered by feed manufacturers 
in diet formulation. 
The applicant provided data on the influence of manganese chelate of glycine, hydrate, or manganese 
sulphate monohydrate (10 mg Mn/L) on the stability of vitamins A, D3 and E in a liquid vitamin–
mineral mixture, also containing iron, copper and zinc. The vitamin concentration was compared to a 
control mixture, without addition of trace elements, after 2 weeks of storage. The three vitamins were 
stable in the presence of the trace element sources tested.50 
3.1.7. Conditions of use 
All manganese compounds under application are intended to be administered to feedingstuffs via a 
premixture. The use of three compounds (manganous chloride, tetrahydrate; manganous sulphate, 
monohydrate; manganese chelate of glycine, hydrate) is also applied for use in water for drinking for 
all animal species and categories, except fish (for details, see Table 2). 
The maximum manganese contents proposed for water for drinking are derived from the maximum 
contents set for complete feed by a factor (ratio of water/feed intake) of 7 for milk replacer, of 10 for 
ovine and of 2–3 for other species (see Table 2). It is noted that the provided manganese calculations 
for use in water for drinking do not consider the background manganese content in feed. 
  
                                                          
48 Technical Dossier/Supplementary Information (April 2015)/Annex_Qxxiv_Mn glycinate_stability water_microbio (T0).pdf. 
Annex_Qxxiv_Mn glycinate_stability water_microbio (T24).pdf. Annex_Qxxiv_Mn glycinate_stability water_microbio (T48).pdf. 
49 Technical Dossier/Section II/Annex 2.4.9. 
50 Technical Dossier/Section II/Annex 2.4.15. 
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Table 2:  Maximum contents of manganese in complete feed and water for drinking, as proposed by 
the applicant 
Animal species/category Maximum total manganese content 
Complete feed (mg/kg) Water for drinking(mg/L)(a) 
Fish 100  
Pigs 
150 
68 
Ovine 15 
Equine 75 
Poultry 75 
Bovine: Milk replacer 
            Other bovine 
21 
50 
(a): The proposed manganese content in water assumes that no manganese is administered via feed (including feed 
background). 
3.2. Safety 
3.2.1. Safety for the target species 
Tolerance studies are not required for compounds of trace elements already authorised (Regulation 
(EC) No 429/2008). The assessment of manganese safety for the target species is based on a 
previous opinion of the SCAN (EC, 2002) and on FEEDAP Panel opinions (EFSA, 2009a, 2010a, EFSA 
FEEDAP Panel 2013a, 2013b, 2013c). 
Manganese is an essential trace element in livestock nutrition. Its essentiality in livestock nutrition 
(poultry) became evident in the 1930s (Lyons and Insko, 1937; Wilgus et al. 1937; Schaible et al., 
1938). 
Manganese has a long history of safe use in animal feeding. In general, manganese is considered to 
be one of the least toxic essential trace elements for farm animals. Depressed iron status and 
haematological changes are the most common signs of manganese toxicosis, also observed in animals 
fed adequate levels of iron (NRC, 2005). The National Research Council defined in 2005 maximum 
tolerable levels (MTL, in mg/kg DM) for ruminants and poultry (2000), pigs (1000) and horses (400), 
whereas no MTL could be derived for fish because of insufficient data (NRC, 2005). The current 
authorised maximum total contents in complete feed in the EU (100 mg/kg for fish and 150 mg/kg for 
other animal species) provide a sufficient margin of safety to the MTLs as well as a sufficient margin 
of safety to the allowances, with estimated requirements for chicken and turkeys for fattening of 60 
mg/kg, for laying hens of 30 mg/kg, for pigs and cattle of 15–25 mg/kg (GfE, 1999, 2001, 2008; NRC, 
1994, 2001; Suttle, 2010). 
Regarding the use of some of the compounds in water for drinking, it appears that the maximum 
manganese concentration in water for drinking as proposed by the applicant (Table 2) was derived 
from calculations in which no manganese background of feed and a low water intake of animals 
(mainly only 2 L/kg feed) were considered. For poultry, pigs and calves (fed milk replacer), 50, 33 and 
18 mg Mn/L water for drinking were derived, respectively, as safe maximum concentrations; the 
corresponding values for dairy cows are 2,405 mg Mn/day and for cattle for fattening 240 mg Mn/100 
kg bw (body weight) (for further details, see Appendix D). 
The FEEDAP Panel notes that the above calculated maximum manganese concentrations and daily 
doses that could be applied via water for drinking can only be used if feed not supplemented with 
manganese is given. It is also noted that the calculations do not consider the manganese content of 
water for drinking. Consequently, the FEEDAP Panel reiterates its recommendation that compounds of 
trace elements should generally not to be used via water for drinking (EFSA, 2010b). 
As the additives contain nickel as a contaminant, the FEEDAP Panel assessed the impact of nickel on 
safety for the target species. According to the NRC (2005), horses, fish and rodents are the most 
sensitive animal species to nickel with a MTL of 50 mg/kg feed. In the worst-case scenario, the nickel 
that would be added to the feed if supplemented with manganese chelate of amino acids, hydrate 
would amount to less than 0.5 mg/kg feed for horses. Together with the background nickel in feed 
(i.e. 4 or 9 mg/kg DM feed; Nicholson et al., 1999; Van Paemel et al., 2010; EFSA CONTAM Panel, 
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2015), the total nickel would then amount up to 9.44 mg Ni/kg feed, corresponding to approximately 
20% of MTL of the sensitive animal species. Therefore, the nickel content of the additives does not 
represent a safety concern for the target species. 
Interactions 
Manganese and iron compete for absorption sites. Fibre, phytate, calcium, phosphorus and 
magnesium may also interfere with manganese absorption. The manganese compounds under 
assessment are not expected to show any relevant interactions with feed components other than 
those well recognised for manganese. 
Conclusions on the safety for the target species  
The FEEDAP Panel concludes that all the manganese compounds under application are considered 
safe for all animal species/categories, provided that the current maximum total contents of 
manganese authorised in feed (100 mg/kg complete feedingstuffs for fish and 150 mg/kg for other 
species) are respected. 
3.2.2. Safety for the consumer 
Metabolic and residue studies 
Manganese is absorbed through the small intestine by non-saturable simple diffusion (Bell et al., 
1989) or by a carrier-mediated transport mechanism with high affinity and low capacity (Garcia-
Aranda et al., 1983). Typical apparent absorption may be in the range of 3–5%; however, values as 
high as 40% have been observed in veal calves with a supply of only 0.6 mg Mn/kg milk replacer 
(Kirchgessner and Neese, 1976). Absorption in poultry is lower, explaining the higher requirement. 
Intestinal absorption of manganese is also inversely related to iron intake (Lönnerdal, 1997). 
Manganese absorbed into portal circulation is transported by α2-macroglobulins or albumin to the 
liver. The major portion of manganese in the liver is secreted into bile. Consequently, manganese is 
primarily excreted via faeces. Urinary excretion of manganese is only a minor route of excretion; it 
reflects endogenous homeostatic regulation and is not related to the dietary intake (NRC, 2005). 
The highest concentrations of manganese are found in the liver, pancreas and kidney and the lowest 
levels occur in bone and fat. Nevertheless, manganese deposition in any of these tissues is not 
considered a valuable indicator of manganese availability in the gut (Jongbloed et al., 2002). 
Manganese deposition studies 
Residue/deposition studies are not required for an already approved compound of trace elements. 
The applicant provided a report of publications comparing organic and inorganic manganese 
compounds based on a total of 14 experiments performed with manganese combined with other 
minerals (seven with Cu/Fe/Zn, six with Cu/Zn and one Cu/Fe). The table in Appendix E summarises 
the data of these studies on manganese deposition in liver, muscle or eggs. 
In four experiments (Mabe et al, 2003; Ao and Pierce, 2006; Huyghebaert, 2006; Dobrzanski et al., 
2008), organic manganese sources did not influence the manganese content of the egg (total, egg 
yolk and egg albumin) differently to inorganic sources. 
Only one study (Kinal et al., 2007) comparing the effect of organic and inorganic manganese sources 
on manganese content of milk was submitted; no differences were found. 
Another comparison of inorganic and organic manganese sources was made regarding manganese in 
liver (one study in broilers (Bao et al., 2007), two in piglets (Schiavon et al., 2000; Martin et al., 2011) 
and two in dairy cows (Olson et al., 1999; Nocek et al., 2006)). The results showed no evidence for 
different deposition of manganese in liver between the two manganese sources in four of the five 
studies submitted. Nevertheless, one study (Martin et al., 2011) showed that manganese in liver was 
increased when a diet with an organic manganese source was fed. 
Four studies reported manganese deposition in muscle following supplementation with organic and 
inorganic sources. One study in piglets (Martin et al., 2011) showed that deposition in muscle 
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occurred at very low level upon supplementation with either an organic or an inorganic source, albeit 
manganese deposited in muscle was higher with the organic source. One study in chickens for 
fattening (Petrovic et al., 2010) reported no differences in manganese muscle deposition between 
organic and inorganic sources. Two studies in rainbow trout were available, yielding different results: 
Apines et al. (2003) observed a twofold increase in whole body manganese when supplementation 
was done by the organic source; however, this finding was not confirmed by a subsequent publication 
of the same group (Apines et al., 2004). The overall evidence suggests that muscle tissue is not an 
important deposition site for manganese, irrespective of the supplementation source. 
Toxicological profile of manganese. Toxicological reviews 
Manganese is essential in the nutrition of both animals and humans. The FEEDAP Panel reviewed the 
relevant literature and considered several previous toxicological assessments of manganese. It is 
noted that there are relatively limited data available on oral toxicity in laboratory animals and humans. 
As is the case for all transition metals, long-term exposure to high doses of manganese poses a risk. 
The toxicology of manganese has been reviewed by the Scientific Committee on Food (SCF) (EC, 
2000), the UK Expert Group on Vitamins and Minerals (EVM 2002, 2003), the US Environmental 
Protection Agency (EPA, 2003), the UK Institute of Environment and Health (IEH, 2007) and most 
recently the US Agency for Toxic Substances and Disease Registry (ATSDR, 2012). The toxicology of 
manganese has been recently reviewed by Lucchini et al. (2015). There is a consensus that the main 
toxic effects of manganese in humans concern the nervous system, the respiratory system (inhalatory 
exposure) and, to a lesser extent, the reproductive system. 
Chronic severe toxicity is primarily associated with effects on the central nervous system (CNS), 
especially through inhalation and long-term exposure, and is considered much more relevant than 
acute effects (Huang et al., 1989; cited by IEH, 2007). Common neurological symptoms arising from 
chronic manganism tend to occur in phases and start with anorexia, weakness and apathy, followed 
by a second phase of hallucinations, delusions and insomnia. During the later stages of chronic 
toxicity, Parkinson-like symptoms such as tremor and muscle rigidity take place. Although manganism 
and true idiopathic Parkinson disease cause very similar deficits within the CNS, they differ in the 
neurotransmitters upon which they act; manganese toxicity results principally in the degeneration of 
γ-aminobutyric acid-ergic neurons in the globus pallidus whilst Parkinson disease is more associated 
with the dopaminergic neurons in the basal ganglia (Roth, 2006; cited by IEH, 2007). 
Manganese aggregates into non-haem iron regions of the brain such as the globus pallidus, substantia 
nigra and subthalamic nuclei (Aschner et al., 2007). Although the precise mechanisms by which 
manganese induces toxic effects within the CNS are a matter of continuing debate, there are a 
number of reports which highlight possible interactions between manganese and other trace elements 
such as iron, copper and aluminium (IEH, 2007). Postulated mechanisms of manganese-induced 
neurotoxicity include (i) increased production of reactive oxygen species (Cohen, 1984; cited by IEH, 
2007); (ii) neuronal degeneration by means of activation of glutamate-gated channels (Brouillet et al., 
1993; cited by IEH, 2007); (iii) manganese in a divalent (or higher) oxidation state exerting toxicity on 
dopamine (Archibald and Tyree, 1987; cited by IEH, 2007); (iv) dopamine oxidation by manganese 
causing oxidative DNA damage (Oikawa et al., 2006, cited by IEH, 2007); and (v) production of 6-
hydroxydopamine (or other toxic catecholamines; Graham, 1984; cited by IEH, 2007). Another 
publication focuses on dopamine oxidation and mitochondrial damage as the main mode of action 
(Farina et al., 2013). 
There are association studies suggesting that, as in animal models, excess manganese exposure in 
humans can lead to reproductive toxicity, resulting in decreased fertility and increased foetal 
abnormalities (Lauwerys et al., 1985; cited by IEH, 2007; Crossgrove and Zheng, 2004; cited by IEH, 
2007). For example, in one study, manganese-exposed male workers were found to have fewer 
children than others (Lauwerys et al., 1985; cited by IEH, 2007). However, other studies did not find 
the same effect (IEH, 2007). 
The results of in vitro studies show that at least some chemical forms of manganese have mutagenic 
potential (ATSDR, 2012). The issue of manganese genotoxicity has been recently reconsidered by 
Lima et al. (2011); available data confirm that manganese can exert genotoxic effects in human 
lymphocytes ex vivo without any marked concurrent cytotoxicity. Likely mechanisms include oxidative 
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damage (as a transition metal, manganese is a potential reactive oxygen species inducer) and the 
interaction with DNA polymerases and other proteins involved with DNA-dependent processes (Wafik 
et al., 1984). The results of in vivo studies in rodents are inconsistent, and in its assessment of 
manganese, ATSDR (2012) was unable to draw an overall conclusion about the possible genotoxic 
hazard to humans from exposure to manganese compounds. 
Information on in vivo chronic toxicity of manganese comes from the National Toxicology Program 
(NTP), which conducted two chronic studies in rats and mice (NTP, 1993). F344/N rats were exposed 
orally for 2 years to manganese from manganous sulphate at 60, 200 or 465 mg/kg bw (males) or 70, 
230 or 714 mg/kg bw (females). Under the conditions of this 2-year feeding study, there was no 
evidence of carcinogenic activity of manganese (II) sulphate monohydrate in male or female rats 
(NTP, 1993). In a 2-year study in B6C3F1 mice, the animals were exposed orally to 160, 540 or 1,800 
mg Mn/kg bw (males) or 200, 700 or 2,250 mg Mn/kg bw (females). There was equivocal evidence51 
of carcinogenic activity of manganese (II) sulphate monohydrate in male and female mice, based on a 
marginally increased incidence of thyroid gland follicular cell adenoma and a significantly increased 
incidence of follicular cell hyperplasia. The ingestion of diets containing manganese (II) sulphate 
monohydrate was associated with focal squamous hyperplasia of the forestomach in male and female 
mice, and ulcers and inflammation of the forestomach in male mice. EVM (2002) echoed the 
conclusions by NTP (1993) and stated that ‘Chronic carcinogenicity studies of manganese sulphate in 
mice and rats were essentially negative, with equivocal evidence of carcinogenicity being observed in 
mice only’. There is no epidemiological or other evidence suggesting that manganese causes cancer in 
humans (ATSDR, 2012; Lucchini et al., 2015). 
Assessment of consumer safety 
See previous FEEDAP Panel opinions on re-evaluation of manganese compounds as feed additives 
(EFSA FEEDAP Panel, 2013a, 2013b, 2013c). 
Conclusions on safety for consumers 
The usual intake levels of dietary manganese do not appear to be associated with any adverse health 
effects in humans, albeit it is advisable that oral exposure to manganese should not increase over the 
background intake. Tissues and products of animal origin generally provide a low contribution to the 
overall manganese dietary intake and are not influenced to any important degree by the 
supplementation of feeds at the current maximum authorised levels in the EU, irrespective of whether 
the source is inorganic or organic. Moreover, due to the long history of use of manganese 
supplementation of feed for food-producing animals, the dietary intake data in humans are expected 
to include foods derived from animals reared with manganese-supplemented feed. It is concluded that 
the use of the manganese compounds under assessment in animal nutrition is of no concern for the 
safety of consumers, provided that the current maximum total contents of manganese authorised in 
feed are respected.52 
3.2.3. Safety for users/workers  
No specific studies were provided by the applicant regarding the toxicity of the additives for 
users/workers. 
Effects on skin and eyes 
Two of the compounds under assessment, manganous sulphate and manganous chloride, react acidic 
at contact with water; these salts are considered as irritants after contact with eyes and mucosae, but 
not irritating or sensitisers to skin (Ikarashi et al., 1992; Basketter et al., 1999; ATSDR, 2012; Lucchini 
et al., 2015).53 Another additive, the insoluble manganous oxide, is not a skin irritant or skin 
sensitiser, but may mechanically irritate the eyes after exposure (ATSDR, 2012).54 The limited 
                                                          
51 ‘Equivocal evidence’ of carcinogenic activity is demonstrated by studies that are interpreted as showing a marginal increase in 
neoplasms that may be chemical related (NTP, 1993). 
52
 100 mg total Mn/kg for fish and 150 mg total Mn/kg for other species. 
53 Technical Dossier/Section II/MSDS Manganous chloride, tetrahydrate; MSDS Manganous sulphate, monohydrate. 
54 Technical Dossier/Section II/MSDS Manganous oxide. 
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database available55 indicates that the manganese chelate of glycine, hydrate and the manganous 
chelate of amino acid, hydrate may irritate skin and eyes and, for the latter, owing to its 
proteinaceous nature, should be considered as a skin sensitiser. The presence of nickel in the 
additives may induce contact dermatitis in workers. 
Effects on the respiratory system 
Manganese is a recognised workplace toxicant upon inhalation exposure. Inhalation of manganese can 
result in pulmonary oedema and tracheobronchitis (Nemery, 1990; cited by IEH, 2007). Furthermore, 
inhaled manganese is particularly hazardous as it can be transported directly to the brain, bypassing 
the intestinal absorption control and liver metabolism (ATSDR, 2012). Some studies suggest that 
manganese inhalation can result in adverse cognitive effects, such as attention deficit and amnesia 
(ATSDR, 2012) as well as parkinsonism-like symptoms (Park, 2013). Individuals subject to prolonged 
occupational exposure to high levels of manganese are considered to be most at risk. Thus, welders, 
miners and other metal industry workers have increased incidence of pulmonary conditions such as 
pneumonia and bronchitis (Saric and Piasek, 2000; cited by IEH, 2007). The lung epithelium functions 
as a barrier to infection and its ability to respond to foreign antigens is disrupted in the presence of 
manganese along with many other transition metals. In a study by Roth and Garrick (2003; cited by 
IEH, 2007), manganese was regarded as the second most important metal, after copper, in causing 
inflammation of the lung tissue. This inflammation is thought to occur by means of cytokine release 
(interleukins) as opposed to being immunoglobulin E mediated. 
All manganese compounds under assessment have fractions of particle sizes < 50 µm (i.e. inhalable) 
exceeding 1%. The dusting potentials are in the range between 0.15 g/m3 (manganese chelate of 
amino acids) and 6.9 g/m3 (manganous sulphate monohydrate). Therefore, exposure of workers/users 
by inhalation when handling the product is likely to be high. Moreover, some of the additives are 
water soluble and can potentially be absorbed by the epithelium of the upper respiratory tract to 
become available to the circulatory system. The human body has an effective control system which 
normally prevents the intestinal absorption of an excess of manganese from the diet; however, this 
system is bypassed upon inhalation exposure of soluble manganese compounds. 
The Health and Safety Executive (HSE) of the UK and the Occupational Safety and Health 
Administration (OSHA) of the US have set an occupational exposure standard for dust from 
manganese and its compounds (HSE, 2003; OSHA, 2007) of 5 mg Mn/m3. In the 2013 edition of its 
TLVs and Biological Exposure Indices publication, the American Conference of Governmental Industrial 
Hygienists reduced the threshold limit value (TLV) for inhalable manganese particles to 0.1 mg/m³. 
The corresponding value for respirable fractions of manganese was set to 0.02 mg/m³. The new TLVs 
do not distinguish between the form of manganese found in welding fume and other forms of 
manganese and are thus relevant for the additives under consideration. Owing to the manganese 
content in the additives, the manganese concentration in the dust produced by the additives in the 
Stauber–Heubach apparatus can greatly exceed the TLV value (manganese chloride: 40 mg/m3; 
manganous oxide: 2,530 mg/m3; manganese sulphate, monohydrate: 2,140 mg/m3; manganese 
chelate of amino acids, hydrate: 90 mg/m3; manganous chelate of glycine, hydrate: 330 mg/m3). 
Therefore, exposure of persons handling the additives poses a risk of inhalation toxicity. 
The FEEDAP Panel considered whether the presence of nickel in the additives under evaluation would 
pose additional concerns to the safety of users. The nickel content of the additives under assessment 
was provided and reached concentrations close to 900 mg/kg of the additive for manganous sulphate, 
monohydrate and manganous oxide. Inhalation of soluble nickel can cause pulmonary toxicity, 
resulting in bronchitis, fibrosis and lung cancer in humans. The proposed occupational exposure limit 
(OEL) for the inhalable fraction of water-soluble nickel is 0.01 mg/m3 (EC, 2011). Considering the 
dusting potential and the nickel content of the additives, the nickel released in the dust from handling 
manganous sulphate, monohydrate and manganese chelate of glycine hydrate is more than two 
orders of magnitude higher than the proposed OEL, that of chelate of amino acids, hydrate one order 
of magnitude. 
Conclusions on safety for the users/workers 
                                                          
55 Technical Dossier/Section II/MSDS Manganese amino acid chelate; MSDS Manganese glycinate chelate. 
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Manganese chloride, tetrahydrate, manganous sulphate, hydrate and manganous oxide are not 
irritants to skin or dermal sensitisers; these three compounds should be considered as eye irritants. It 
is prudent to regard the manganese chelate of glycine, hydrate, and the manganous chelate of amino 
acid, hydrate, as irritants to skin and eyes, and the amino acid chelate as a dermal sensitiser. 
Due to the high dusting potential, all manganese compounds under assessment can cause respiratory 
toxicity in persons handling the additive. 
The nickel content in the dust of manganous sulphate, monohydrate, manganese chelate of glycine 
hydrate and the manganese chelate of amino acids, hydrate represents a risk by inhalation. Moreover, 
the presence of nickel in all additives may induce contact dermatitis in users. 
3.2.4. Safety for the environment 
Manganese is the second most abundant (after iron) transition element in the Earth’s crust, with an 
estimated global average in soil of 437 mg/kg (Forum of European Geological Surveys, FOREGS),56 
ranging from 40 to 900 mg/kg (Lucchini et al., 2015). The median concentration of manganous oxide 
in 845 samples of topsoil collected throughout Europe for the FOREGS survey was 650 mg/kg and the 
manganese content of the acid-soluble fraction (Aqua regia) contained 382 mg/kg, with a range of 
< 10‒6,480 mg/kg (FOREGS). The behaviour of manganese in soil is very complex and is controlled 
by different environmental factors, of which pH-Eh conditions are the most important (Kabata-Pendias 
2001). Mn2+ appears to have low affinity for organic ligands (Lazerte and Burling, 1990; Chiswell and 
Zaw 1991). However, whilst the Mn2+ (aqueous) ion is readily soluble, manganese in soil is not very 
mobile, because Mn3+ and Mn4+ form insoluble hydrous oxides, especially under oxidising conditions. 
Concentrations of dissolved manganese in European stream waters from the FOREGS survey range 
from < 0.05 to 698 μg/L, with a median value of 15.9 μg/L (n= 804). The lowest values of dissolved 
manganese (< 1.7 μg/L) are found in central and northern Sweden, in central and south Norway, and 
in western Scotland and western England on Caledonian terrains (FOREGS). 
Environmental safety from use in feeds for terrestrial farm animals 
Based on the calculation method provided in the technical guidance for assessing the safety of feed 
additives for the environment (EFSA, 2008b), the highest theoretical addition of manganese in soil 
(PECsoil) from animal feeds is around 3 mg/kg (lambs) after a 1-year application of manure assuming 
that 100% of a dose will be excreted. As the median content of manganese in European soil is over 
two orders of magnitude higher than this value, the use of manganese in animal feeds at the 
legislated inclusion levels is not expected to pose a risk to the soil compartment. 
Environmental safety from use in aquaculture feeds 
Using its technical guidance for assessing the safety of feed additives for the environment (EFSA, 
2008b), the FEEDAP Panel calculated the worst-case concentrations in the environment resulting from 
the supplementation of fish feeds with the manganese compounds under assessment at the total level 
of 100 mg Mn/kg. When fed to fish in sea cages, the sediment under the cage is considered the 
compartment of concern (EFSA, 2008b). The PECsed was calculated to be 21.2 mg/kg wet weight, 
which substantially exceeds the threshold for Phase I assessment (10 μg/kg). However, manganese 
concentrations in top sediment in marine and estuarine environments vary widely from 10 to at least 
4,000 mg/kg, which in all cases by far exceeds that maximally emitted from aquaculture (Sadiq and 
Zaidi, 1985; Cahill and Unger, 1993; Galasso et al., 2000; Sahli et al., 2011). For land-based 
aquaculture operations, such as ponds and raceways, the surface water downstream of the fish farm 
is considered the most sensitive compartment (EFSA, 2008b). The PECswaq was calculated to be 
0.07-0.25 μg /L, depending on the species. This concentration slightly exceeds the trigger value, but 
is yet two orders of magnitude lower than the median concentration of manganese in European 
freshwaters (FOREGS). 
Conclusions on environmental safety 
                                                          
56 Available online: http://weppi.gtk.fi/publ/foregsatlas/ 
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The use of the manganese compounds under assessment (manganous chloride, tetrahydrate; 
manganous sulphate, monohydrate; manganous oxide; manganese chelate of amino acids, hydrate; 
manganese chelate of glycine, hydrate) in animal nutrition for all animal species is safe for the 
environment, provided that the current maximum total contents of manganese authorised in feed are 
respected. 
3.3. Efficacy 
No efficacy studies are required for compounds of trace elements already authorised as feed 
additives. 
The use of the manganese compounds under assessment in animal nutrition is extensively 
documented in the scientific literature and summarised by McDowell (2003) and Suttle (2010). They 
are recognised as efficacious sources of manganese in meeting animals’ requirements. 
3.4. Post-market monitoring 
The FEEDAP Panel considers that there is no need for specific requirements for a post-market 
monitoring plan other than those established in the Feed Hygiene Regulation57 and good 
manufacturing practice. 
4. Conclusions 
The manganese compounds under consideration are: manganous chloride, tetrahydrate; manganous 
sulphate, monohydrate; manganous oxide; manganese chelate of amino acids, hydrate and 
manganese chelate of glycine, hydrate. The safety assessment is based on the assumption that the 
current maximum total contents of manganese authorised in feed are respected. 
All manganese compounds under application are considered safe for all animal species/categories. 
The mean manganese intake of the European population includes already the manganese from animal 
products and does not pose a toxicological concern. The effect of dietary manganese fed to animals 
on tissue concentrations is limited. Supplementation of feed with the manganese compounds under 
assessment would consequently not affect consumer exposure and is of no concern for consumer 
safety. 
All manganese compounds are considered as eye irritants, the manganese chelate of glycine and the 
manganese chelate of amino acids as irritants to skin and the latter one as dermal sensitiser. 
However, the presence of nickel in all additives may induce contact dermatitis. Exposure to 
manganese in dust of all additives and to nickel (except manganous chloride and manganous oxide) 
poses a risk to users by inhalation. 
The use of the manganese compounds under assessment in animal nutrition for all animal species is 
not expected to pose a risk to the environment. 
The manganese compounds under assessment are recognised as efficacious sources of manganese in 
meeting animals’ requirements. 
5. Recommendations 
For all manganese compounds, monitoring of the nickel content, and for manganous oxide monitoring 
of mercury content, should be included in the HACCP plan. Attempts should be made for a continuous 
reduction in the nickel content. 
Concerning the manganese chelate of amino acids, hydrate, the FEEDAP Panel identified in a previous 
assessment (EFSA FEEDAP Panel, 2013b) and in the current one that the description of the compound 
does not meet the terms of the current legislation: ‘molecular weight not exceeding 1500 dalton’. Data 
from different companies reveal that up to 30% of the molecules may have a molecular weight 
exceeding 1500 Da. A previous assessment of manganous chelate of amino acids, hydrate considered 
                                                          
57 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements 
for feed hygiene. OJ L 35, 8.2.2005, p. 1. 
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these new findings by recommending the characterisation of the molecular weight by ‘At least 90% of 
the molecules should have a molecular weight not exceeding 1500 dalton’. The Panel recommends to 
keep this definition further on for chelates which match this criteria. However, there would be another 
group of chelates ‘More than 10% of the molecules having a molecular weight exceeding 1500 
dalton’; consequently, this group of chelates, chemically different from the former group, requires a 
different name. The Panel proposes ‘Chelates of protein hydrolysates’. In summary, the Panel 
recommends the classification of manganese chelates into two groups, for which the following names 
and characteristics are proposed: 
 Manganese chelate of amino acids, hydrate: Not more than 10% of the molecules exceeding 
1500 Da 
 Manganese chelate of protein hydrolysates: Between 10% and 50% of the molecules 
exceeding 1500 Da 
In both the above cases, at least 50% of the manganese should be present as chelate. 
For both groups, the general formula of Mn(x)1-3•nH2O (x is the anion of any amino acid from soya 
protein hydrolysate) is proposed. 
For user safety, the workplace concentration of manganese should not exceed 0.02 mg Mn/m3. 
Maximum contents for total manganese in feed are set by legislation. The conclusions of the FEEDAP 
Panel on the safety of the five manganese compounds assessed for the target animals, the consumer 
and the environment are only valid if these maximum contents are strictly considered in feed 
formulation. As manganese is routinely supplemented to feed, only a small amount, if any, could be 
administered additionally via water for drinking. Exact dosing in water for drinking can only be made if 
the total dietary manganese content is known, which is normally not the case. The FEEDAP Panel 
therefore does not recommend the use of manganese compounds via water for drinking. The 
simultaneous use of feed and water both supplemented with manganese should be avoided. 
Considering the mentioned caveat, the following concentrations/daily doses comply with the maximum 
content authorised for feed: poultry, 50 mg Mn/L; pigs, 33 mg Mn/L; calves (fed milk replacer), 18 mg 
Mn/L; dairy cows, 2405 mg Mn/day; cattle for fattening, 240 mg Mn/100 kg bw per day. 
The FEEDAP Panel stresses the general need for analytical methods to quantify the organic 
compounds of trace elements in feed. 
Documentation provided to EFSA 
1. Dossier Manganese (E5). Nutritional feed additive. Compounds of trace elements. February 
2010. Submitted by TREAC EEIG (Trace Elements Authorisation Consortium). 
2. Dossier Manganese (E5). Nutritional feed additive. Compounds of trace elements. 
Supplementary information. April 2015. Submitted by FEFANA asbl. 
3. Dossier Manganese (E5). Nutritional feed additive. Compounds of trace elements. 
Supplementary information. August 2015. Submitted by FEFANA asbl. 
4. Evaluation report of the European Union Reference Laboratory for Feed Additives on the 
methods(s) of analysis for Manganese (E5). 
5. Comments from Member States received through ScienceNet. 
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ATSDR Agency for Toxic Substances and Disease Registry 
As Arsenic 
bw body weight 
CAS Chemical Abstracts Service 
Cd Cadmium 
CFU colony-forming units 
CNS central nervous system 
Cu Copper 
CV coefficient of variation 
DM dry matter 
EC European Commission 
EEC European Economic Community 
EURL European Union Reference Laboratory 
EVM Expert Group on Vitamins and Minerals 
F fluorine 
Fe iron 
FEEDAP Panel on Additives and Products or Substances used in Animal Feed 
FEFANA EU Association of Specialty Feed Ingredients and their Mixtures 
FOREGS Forum of European Geological Surveys 
HACCP Hazard Analysis Critical Control Points 
Hg mercury 
HSE Health and Safety Executive 
IEH Institute of Environment and Health 
MTL maximum tolerable level 
Mn manganese 
Ni nickel 
NTP National Toxicology Program 
NRC National Research Council 
OEL occupational exposure limit 
OSHA Occupational Safety and Health Administration 
Pb lead 
PCBs polychlorinated biphenyls 
PCDDs polychlorinated dibenzo-para-dioxins 
PCDFs polychlorinated dibenzofurans 
PECsoil predicted environmental concentrations in soil 
PECsw predicted environmental concentrations in surface water 
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SCAN Scientific Committee on Animal Nutrition 
SCF Scientific Committee on Food 
TEQ toxic equivalent factor 
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TMR total mixed ration 
TREAC EEIG Trace Elements Authorisation Consortium European Economic Interest Grouping 
WHO World Health Organization 
Zn zinc 
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Appendix A – List of Risk Assessment Reports on manganese and 
manganese compounds 
Besides the reports cited in the Background section and in the text as references, risk assessments 
from other EU bodies and Institutions have been carried out.  
1. EC Health and Consumers Scientific Committees Opinions 
Scientific Committee on Food. Opinion on arsenic, barium, fluoride, boron and manganese in natural 
mineral waters (Expressed on 13 December 1996) 
(http://ec.europa.eu/food/fs/sc/oldcomm7/out09_en.html) 
2. European and other countries Risk Assessment Reports 
Food Standard Agency Risk Assessment Manganese 
(http://www.food.gov.uk/multimedia/pdfs/evm_manganese.pdf) 
3. EFSA ANS Panel Opinions 
Manganese ascorbate, manganese aspartate, manganese bisglycinate and manganese pidolate as 
sources of manganese added for nutritional purposes to food supplements - Scientific Opinion of the 
Panel on Food Additives and Nutrient Sources added to Food (ANS). 
(http://www.efsa.europa.eu/en/efsajournal/doc/1114.pdf) 
4. EFSA CEF Panel Opinions 
Scientific Report of EFSA on the risk assessment of salts of authorised acids, phenols or alcohols for 
use in food contact materials.  
(http://www.efsa.europa.eu/en/efsajournal/doc/1364.pdf) 
5. EFSA NDA Panel Opinions  
Scientific Report submitted to EFSA - Literature search and review related to specific preparatory work 
in the establishment of Dietary Reference Values: Preparation of an evidence report identifying health 
outcomes upon which Dietary Reference Values could potentially be based for chromium, manganese 
and molybdenum. (http://www.efsa.europa.eu/en/efsajournal/doc/1147.pdf) 
Scientific Opinion on the substantiation of health claims related to manganese and protection of DNA, 
proteins and lipids from oxidative damage (ID 309), maintenance of bone (ID 310), energy-yielding 
metabolism (ID 311), and cognitive function (ID 340) pursuant to Article 13(1) of Regulation (EC) No 
1924/2006. (http://www.efsa.europa.eu/en/efsajournal/doc/1217.pdf) 
 
Scientific Opinion on the substantiation of health claims related to manganese and reduction of 
tiredness and fatigue (ID 312), contribution to normal formation of connective tissue (ID 404) and 
contribution to normal energy-yielding metabolism (ID 405) pursuant to Article 13(1) of Regulation 
(EC) No 1924/2006. (http://www.efsa.europa.eu/en/efsajournal/doc/1808.pdf)  
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Appendix B – List of authorisations of manganese compounds other than 
as feed additives 
The following manganese compounds are authorised for use in food (Regulation (EC) No 
1170/2009):58 manganese ascorbate, manganese L-aspartate, manganese bisglycinate, manganese 
carbonate, manganese chloride, manganese citrate, manganese gluconate, manganese 
glycerophosphate, manganese pidolate and manganese sulphate which may be used in the 
manufacture of food supplements; manganese carbonate, manganese chloride, manganese citrate, 
manganese gluconate, manganese glycerophosphate and manganese sulphate which may be  used in 
the manufacture of  food supplements and may be added to food. 
The following manganese compounds can be used for the manufacturing of dietetic foods 
(Commission Regulation (EC) No 953/2009):59 manganese carbonate, manganese chloride, 
manganese citrate, manganese gluconate, manganese glycerophosphate and manganese sulphate. 
The following manganese compounds can be used for the manufacturing of processed cereal-based 
foods and baby foods for infants and young children (Commission Directive 2006/125/EC):60 
manganese carbonate, manganese chloride, manganese citrate, manganese gluconate, manganese 
glycerophosphate and manganese sulphate. 
Regarding pharmacologically active substances and their classification regarding maximum residue 
limits in foodstuffs of animal origin, the following manganese compounds are listed in Table 1 of the 
Annex of Regulation 37/201061 as Allowed substances, no MRL required: dimanganese trioxide, 
manganese carbonate, manganese chloride, manganese gluconate, manganese glycerophosphate, 
manganese oxide, manganese pidolate, manganese ribonucleate and manganese sulphate. According 
to article 14(7) of Regulation (EC) No 470/200962 these compounds are for oral use only.  
The following manganese compound is listed in Annex of Commission Implementing Regulation (EU) 
No 540/201163 as “Active substances approved for use in plant protection products”: manganese 
ethylenebis (dithiocarbamate, polymeric) (Maneb) and manganese ethylenebis (dithiocarbamate, 
polymeric) complex with zinc salt (Mancozeb). 
The following type of fertilisers for manganese as Fertilisers containing only one micro-nutrient are 
listed in Annex I of Regulation (EC) No 2003/200364 of the European Parliament and of the Council: 
(a) manganese salt (chemically obtained product containing a mineral manganese salt (Mn II) as its 
essential ingredient), (b) manganese chelate (water-soluble product obtained by combining 
manganese chemically with a chelating agent), (c) manganese oxide (chemically obtained product 
containing manganese oxides as essential ingredients), (d) manganese-based fertiliser (product 
obtained by mixing types (a) and (c)) and (e) manganese-based fertiliser solution (product obtained 
by dissolving types (a) and/or one of the type (b) in water). 
                                                          
58 Commission Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European 
Parliament and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards  the 
lists of vitamin and minerals and their forms that can be added to foods, including food supplements. OJ L 314, 1.12.2009, p. 
36. 
59 Commission Regulation (EC) No 953/2009 of 13 October 2009 on substances that may be added for specific nutritional 
purposes in foods for particular nutritional uses. OJ L 269, 14.10.2009, p. 9. 
60 Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and 
young children. OJ L 339, 6.12.2006, p. 16. 
61 Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification 
regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1. 
62 Regulation (EC) no 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community 
procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, 
repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of  the 
Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council OJ L 152, 16.6.2009, p. 11. 
63 Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the 
European Parliament and of the Council as regards the list of approved active substances. OJ L 153, 11.6.2011, p. 1. 
64 Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October 2003 relating to fertilisers. OJ L 
304, 21.11.2003, p. 1. 
Manganese-E5 (five compounds) for all animal species 
 
 
 
 
www.efsa.europa.eu/efsajournal 32 EFSA Journal 2016;14(2):4395 
 
 
The following manganese compounds can be used for cosmetic purposes (Regulation (EC) No 
1223/2009 of the European Parliament and of the Council):65 ammonium manganese (3+) 
diphosphate and trimanganese bis (orthophosphate). 
According to the Annex of Regulation (EC) No 432/201266 the following health claims can be made 
only for food which is at least a source of manganese as referred to in the claim SOURCE OF [NAME 
OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 
1924/200667: manganese contributes to normal energy-yielding metabolism, manganese contributes 
to the maintenance of normal bones, manganese contributes to the normal formation of connective 
tissue and manganese contributes to the protection of cells from oxidative stress. 
  
                                                          
65 Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. OJ 
L 342, 22.12.2009, p. 59. 
66 Commission Regulation (EC) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods,  other 
than those referring to the reduction of disease risk and to children’s development and health. OJ L 136, 25.05.2012, p. 1. 
67 Regulation (EC) No 1924/2006 of the European Parliament and of the council of 20 December 2006 on nutrition and health 
claims made for food. OJ L 404, 30.12.2006, p. 9. 
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Appendix C – Details on the Characterisation and Identity of the 
compounds for which more than one company is involved in 
the application68 
Table 3:  Parameters of characterisation and identity of manganous oxide (number of batches in 
brackets) 
 
 
Company(a) 
b5 b7 
Manganese content (%) 61.7–62.7 (5)(1) 60.3–61.1 (5)(2) 
Pb (mg/kg) 154–165 (5)(3) 71.4–180 (5)(4) 
Cd (mg/kg) 6–7 (5) 5.2–8.2 (5) 
Hg (mg/kg) 0.02–0.06 (3)(5) 0.45–0.68 (5) 
< 0.02–0.04 (22)(6) 
F (mg/kg) --- 90 (1) 
As (mg/kg) 43 (5) 34.1–44 (5) 
Dioxins(b) 0.035–0.094 (4)(7) 0.039–0.090 (2)(8) 
Sum of dioxins and dioxin-like PCBs(c) 0.090–0.064 (2)(9) 0.071–0.121 (2) 
Nickel (mg/kg)(10) 370–400 (3) 681–867 (2) 
Particle size (%)(d) 30.4 (< 50.2 µm) 
13.7 (< 10.0 µm) 
(1)(11) 
41.5 (< 52.6 µm)  
23 (< 10.8 µm) 
(1)(12) 
Dusting potential (g/m3) --- 4.22(13) 
--- : Not provided.  
(1): Technical Dossier/Section II/Annex 2-1-23 and 2-1-41 
(2): Technical Dossier/Section II/Annex 2-1-24 
(3): Technical Dossier/Section II/Annex 2-1-41 and 2-1-23 (For heavy metals (Cd and Pb) and As) 
(4): Technical Dossier/Section II/Annex 2-1-42 and 2-1-24 (For heavy metals (Cd, Hg and Pb) and As) 
(5): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxii_Mn oxide_Mercury.pdf mercury(2)pdf. and          
mercury(3)pdf 
(6): Technical Dossier/ Supplementary Information (April 2015)/Annex_Qxiii_Mn oxide_mercury_Company b7(1)-(22).pdf 
(7): Technical Dossier/Section II/Annex 2-1-59. Technical Dossier/Supplementary Information (April 2015)/Annex_Qxii_Mn 
oxide_Dioxins and Dioxin like PCBs.pdf 
(8): Technical Dossier/Section II/Annex 2-1-60 
(9): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxii_Mn oxide_Dioxins and Dioxin like PCBs.pdf 
(10): Technical Dossier/Supplementary Information (April 2015)/Annex_Qii_Nickel_Mn oxide.pdf 
(11): Technical Dossier/Section II/Annex 2-2-31 
(12): Technical Dossier/Section II/Annex 2-2-32 (the compound measured is not identified) 
(13): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxiv_Mn oxide_Dusting potential.pdf 
 
(a): Two companies: b5 and b7 
(b):Expressed as ng WHO-PCDD/F-TEQ/kg 
(c):Expressed as ng WHO-PCDD/F- PCB-TEQ/kg) 
(d):Technique used. Laser diffraction (expressed as v/v) 
  
                                                          
68
 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003. 
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Table 4:  Parameters of characterisation and identity of manganous sulphate, monohydrate (number 
of batches in brackets). 
 
 
Company(a) 
b7 b12 
Manganese content (%) 31.4–32.1 (4)
(1) 32.0–34.1(6)(2) 
Pb (mg/kg) < 0.5–33 (4)(3) <0.5–9(6)(4) 
Cd (mg/kg) 0.91–16 (4) 0.57–5 (6) 
Hg (mg/kg) < 0.01–< 0.02(4) <0.02–0.2 (6) 
F (mg/kg) < 70 (1) --- 
As (mg/kg) < 0.5–9.7 (4) 0.08–0.19 (6) 
Dioxins(b)  0.047 –0.09 (2)(5) 0.09 (2)(6) 
Sum of dioxins and dioxin-like PCBs(c) 0.073–0.119 (4) 0.137–0.138 (2) 
Nickel (mg/kg)(7) 516–530 (2) 23–891 (5) 
Particle size (%)(d)  6.5 (< 52.6 µm) 
1.6 (< 10.8 µm) 
(1)(8) 
0 (< 50 µm) 
0 (< 10 µm) 
(1)(9) 
Dusting potential (g/m3) 6.89 (1)(10) --- 
--- : Not provided  
(1): Technical Dossier/Section II/Annex 2-1-25 
(2): Technical Dossier/Section II/Annex 2-1-26 and 2-1-44 and  2-1-62 
(3): Technical Dossier/Section II/Annex 2-1-43 and 2-1-25 (For heavy metals (Cd, Hg and Pb) and As) 
(4): Technical Dossier/Section II/Annex 2-1-44 and 2-1-26 (For heavy metals (Cd, Hg and Pb) and As) 
(5): Technical Dossier/Section II/Annexes 2-1-61and 2-1-25 (Dioxin and Sum of dioxin and Dioxin like) 
(6): Technical Dossier/Section II/Annexes 2-1-62 (Dioxin and Sum of dioxin and Dioxin like) 
(7): Technical Dossier/Supplementary Information (April 2015)/Annex_Qii_Nickel_Mn sulphate mono.pdf 
(8): Technical Dossier/Section II/Annex 2-2-33 
(9): Technical Dossier/Section II/Annex 2-2-34 
(10): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxi_Mn sulphate H2O_Dusting potential.pdf 
 
(a): Two companies: b7 and b12 
(b): Expressed as ng WHO-PCDD/F-TEQ/kg 
(c): Expressed as ng WHO-PCDD/F- PCB-TEQ/kg) 
(d): Technique used. Laser diffraction (expressed as v/v) 
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Table 5:  Parameters of characterisation and identity of manganese chelate of amino acid, hydrate (number of batches in brackets) 
 
 
Company(a) 
b1 b2 b4 b9 b12 
Manganese content (%) 10.2–10.6 (5)
(1) 15.2–15.9 (7)(2) 16.1–16.7 (5)(3) 12.2–13.2 (3)(4) 15.1–15.6 (5)(5) 
Pb (mg/kg) < 0.05–<0.1 (3)(6) 6–20 (7)(7) < 0.5 (1)(8) < 0.5–0.31 (3)(9) 0.1–0.8 (3)(10) 
Cd (mg/kg) 0.6–1.2 (3) 1–7(7) < 0.5 (1) < 0.1–<0.5 (3)  0.8–1.8 (3) 
Hg (mg/kg) < 0.005(3) --- < 0.02 (1) < 0.1–<0.5(3) < 0.01(3) 
As (mg/kg) < 0.10–0.25 (3) 1 (1) < 0.5 (1) < 0.5–0.58 (3) 0.2–0.3 (3) 
F (mg/kg) < 10 (3) --- --- --- --- 
Dioxins(b)  0.050–0.148 (3)(11) 0.055 (1)(12) 0.09 (1)(13) 0.015 (1)(14) 0.09–0.16 (4)(15) 
Sum of dioxins and dioxin-like PCBs(c) 0.079–0.186 (3) --- 0.123 (1) 0.016 (1) 0.318 (1) 
Nickel (mg/kg)(16) 141 (1) 20 (1) 144–472 (2) 175–178 (2) 11 (1) 
Particle size (%)(D)  59.8–73.0 (< 52.9 µm) 
19.5–22.5 (< 10 µm) 
(4)(17) 
50.8 (< 50 μm) 
12.6 (< 10 μm) 
(1)(18) 
13.8 (< 63 µm) 
--- 
(1)(19) 
3.9–4.3 (< 50 μm) 
0 (< 10 μm) 
(3)(20) 
59.6 < 52.3 μm  
3.1 < 11 μm 
(1)(21) 
Dusting potential (g/m3) 0.15–0.88 (5)(22,23) --- ---  --- --- 
--- : Not provided  
(1): Technical Dossier/Section II/Annex 2-1-10 
(2): Technical Dossier/Section II/Annex 2-1-11and 2-1-29 
(3): Technical Dossier/Section II/Annex 2-1-13 
(4): Technical Dossier/Section II/Annex 2-1-15 
(5): Technical Dossier/Section II/Annex 2-1-16 
(6): Technical Dossier/Section II/Annex 2-1-28 (For heavy metals (Cd, Hg and Pb) and As) 
(7): Technical Dossier/Section II/Annex 2-1-29 and 2.1.11(For heavy metals (Cd, Hg and Pb) 
and As) 
(8): Technical Dossier/Section II/Annex 2-1-31 and 2-1-49 (For heavy metals (Cd, Hg and 
Pb) and As) 
(9): Technical Dossier/Section II/Annex 2-1-33 and 2-1-15 (For heavy metals (Cd, Hg and 
Pb) and As) 
(10): Technical Dossier/Section II/Annex 2-1-34 and 2-1-52 (For heavy metals (Cd, Hg and 
Pb) and As) 
(11): Technical Dossier/Section II/Annex 2-1-46 (Dioxin and Sum of dioxin and Dioxin like) 
(12): Technical Dossier/Section II/Annex 2-1-47 (Dioxin and Sum of dioxin and Dioxin like) 
(13): Technical Dossier/Section II/Annex 2-1-49 and 2-1-31(Dioxin and Sum of dioxin and 
Dioxin like) 
(14): Technical Dossier/Section II/Annex 2-1-51 (Dioxin and Sum of dioxin and Dioxin like) 
(15): Technical Dossier/Section II/Annex 2-1-52 and 2-1-34 (Dioxin and Sum of dioxin and 
Dioxin like). Technical Dossier/Supplementary Information (April 2015)/Annex_Qxv_Mn 
AA chelate_Company b12_Dioxins and Dioxin like PCBs.pdf 
(16): Technical Dossier/Supplementary Information (April 2015)/Annex_Qii_Nickel_Mn AA.pdf 
(17): Technical Dossier/Section II/Annex 2-2-18 
(18): Technical Dossier/Section II/Annex 2-2-19 
(19): Technical Dossier/Section II/Annex 2-2-21 
(20): Technical Dossier/Section II/Annex 2-2-23 
(21): Technical Dossier/Section II/Annex 2-2-24 
(22): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxvi_Mn chelate 
AA_Dusting potential.pdf 
(23): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxvi_Mn AA 
chelate_Mn in dust.pdf  
 
(a): Five companies: b1, b2, b4, b9 and b12 
(b): Expressed as ng WHO-PCDD/F-TEQ/kg 
(c): Expressed as ng WHO-PCDD/F- PCB-TEQ/kg 
(d): Technique used. b1, b2, b9 and b12 Laser diffraction (expressed as v/v). b4 Sieving 
(expressed as w/w) 
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Table 6:  Microbiological contaminants content of representative batches of manganese chelate of amino acids, hydrate 
Company(a) 
(number of batches) 
Production date 
Date of analysis 
Age (months) Contaminants CFU/g 
b1 (1)(1) March 2010 
 
 
April 2013 
36 Total aerobic plate count 
Total Yeasts and Moulds 
Coliforms 
Salmonella 
< 1.0 × 10(2) 
< 1.0 × 10(1) 
< 1.0 × 10(2) 
Negative in 25 g 
b2 (1)(2) October2010  
 
January 2013 
ca. 27 Total plate count 
Total Yeasts and Moulds 
E. coli 
Salmonella 
< 1.0 × 10(1) 
Negative in 0.1g 
< 1.0 × 10(1) 
Negative in 25 g 
b4 (1)(3) January 2009  
 
December 2012 
35 Yeasts 
Moulds 
Salmonella 
Total aerobic count 
E. coli 
Coliform bacteria 
Bacillus cereus 
< 1.0 × 10(2) 
< 1.0 × 10(2) 
Not detected in 25g 
< 1.0 × 10(2) 
< 1.0 × 10(1) 
< 1.0 × 10(2) 
< 1.0 × 10(2) 
b9 (1)(4) February 2009 
 
March 2012 
ca. 37 Yeasts 
Moulds 
Salmonella 
Total bacterial count - aerobic 
Total bacterial count –  
anaerobic 
Total coliforms 
< 2.0 × 10(1) 
< 2.0 × 10(1) 
Negative in 25 g 
< 0.5 × 10(1) 
< 0.5 × 10(1) 
< 2.0 × 10(1)  
(NPP/g) 
     b12(5) (1) Sept./Oct. 2012 
 
Nov./Dec. 2012 
1-3 Yeasts 
Moulds 
Salmonella 
Total plate count 
Total Coliforms 
< 1.0 × 10(2) 
< 1.0 x 10(2) 
Negative in 25g 
< 1.0 × 10(3) 
< 1.0 × 10(1) 
  
(2) 
 
 
 
 
July 2009/Sept. 2009 
 
November 2012 
38-40 Yeasts 
Moulds 
Salmonella 
Total plate count - aerobic 
Total Coliforms 
< 1.0 × 10(2) 
< 1.0 × 10(2) 
Negative in 25g 
< 1.0 × 10(3) 
< 1.0 × 10(1) 
(1): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxix_Mn chelate AA_mycotoxins and microbio_Company 1.pdf 2-1-62 
(2): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxix_Mn chelate AA_microbio_Company b2.pdf Expressed as ng WHO-PCDD/F-TEQ/kg 
(3): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxix_Mn chelate AA_microbio_Company b4.pdf 
(4): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxix_Mn chelate AA_ microbio_Company b9.pdf 
(5): Technical Dossier/Supplementary Information (April 2015)/Annex_Qxix_Mn chelate AA_mycotoxins and microbio_Company b12.pdf 
(a):  Five companies: b1, b2, b4, b9 and b12   
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Table 7:  Main characteristics of manganese chelate of glycine, hydrate, as supplied by four companies (number of batches in brackets) 
 Company(a) 
b2 b4 b9 b11 
Higher grade Lower grade(1) 
Manganese content (%) 22.1–23.4 (6)(2) 15.8–16.0 (5) 21.8–22.1 (5)(3) 22–23 (3)(4) 26.9–27 (5)(5) 
Pb (mg/kg) 8–10 (6)(6) 8–14 (5) <0.5(3)(7) <0.5 (3)(8) 33.7–34 (3)(9) 
Cd (mg/kg) 1–9 (6) 1–4 (5) 0.79–2.21 (3) <0.5–4 (3) 2.21–2.34 (3) 
Hg (mg/kg) --- --- <0.02 (3) <0.5 (3) <0.0007(3) 
As (mg/kg) 1 ( 1) 1 (5) <0.5 (3) <0.5–0.6 (3) <0.01 (3) 
Dioxins(b) 0.065 (1)(10) 0.043–0.067 (5) 0.09 (2)(11) 0.17 (1)(12) 0.0184 (1)(13) 
Sum of dioxins and dioxin-like 
PCBs(c) 
--- 0.053–0.077 (5) 0.126–0.153 --- 0.0298 
Nickel (mg/kg)(14) 53 --- 178–501 475 96 
Particle size (%)(d) 100 (< 50 µm) 
93.5 (< 10 µm) 
(1)(15) 
--- 10.9 (<52.62 µm) 
4.2 (<10.78 µm) 
(1)(16) 
8.8–9.3 (< 50 µm)  
0.8–0.9 (< 10 µm) 
(3)(17) 
5* (< 50 µm) 
2.5 (< 10 µm) 
 (1)(18) 
Dusting potential (g/m3) 2.23(19) --- --- --- --- 
--- : Not provided  
(1): Technical Dossier/Supplementary Information (April 2015)/Annex_Company 
b2_Composition_Mn chelate glycine_15%_5CoAs.pdf 
(2): Technical Dossier/Section II/Annex 2-1-17 and 2-1-35 
(3): Technical Dossier/Section II/Annex 2-1-18 
(4): Technical Dossier/Section II/Annex 2-1-19 
(5): Technical Dossier/Section II/Annex 2-1-20 
(6): Technical Dossier/Section II/Annex 2-1-35 and 2-1-17 (For heavy metals (Cd, Hg and 
Pb) and As) 
(7): Technical Dossier/Section II/Annex 2-1-36 and 2-1-54 (For heavy metals (Cd, Hg and 
Pb) and As) 
(8): Technical Dossier/Section II/Annex 2-1-19 (For heavy metals (Cd, Hg and Pb) and As) 
(9): Technical Dossier/Section II/Annex 2-1-38 (For heavy metals (Cd, Hg and Pb) and As) 
(10): Technical Dossier/Section II/Annex 2-1-53 (Dioxin and Sum of dioxin and Dioxin like) 
(11): Technical Dossier/Section II/Annex 2-1-54 and 2-1-36 (Dioxin and Sum of dioxin and 
Dioxin like) 
(12): Technical Dossier/Section II/Annex 2-1-55 (Dioxin and Sum of dioxin and Dioxin like) 
(13): Technical Dossier/Section II/Annex 2-1-56 (Dioxin and Sum of dioxin and Dioxin like) 
(14): Technical Dossier/Supplementary Information (April 2015)/Annex_Qii_Nickel_Mn 
glycinate.pdf  
(15): Technical Dossier/Section II/Annex 2-2-25 
(16): Technical Dossier/Section II/Annex 2-2-26 
(17): Technical Dossier/Section II/Annex 2-2-27 
(18): Technical Dossier/Section II/Annex 2-2-28 
(19): Applicant B. Technical Dossier/Supplementary Information (April 
2015)/Annex_Qxxiii_Mn chelate glycine_Dusting potential.pdf 
 
(a): Four companies: b2, b4, b9 and b11 
(b): Expressed as ng WHO-PCDD/F-TEQ/kg 
(c): Expressed as ng WHO-PCDD/F-PCB-TEQ/kg 
(d): Technique used. Laser diffraction (expressed as v/v). (*) Extrapolated from the graph 
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Table 8:  Composition of the manganese chelate of glycine, hydrate, as supplied by three companies 
(number of batches in brackets) 
 
 
Company(a) 
b2-Lower grade(1) b4(2) b9(3) 
Manganese Content (%) 16.2–16.3 (3) 19.5–20.3 (3) 22.4–22.7 (3) 
Extractable glycine (%) 49.9–51.0 (3) 40.6–41.7 (3) 32.2–32.9 (3) 
Sulphur (%) 9.5–9.9 (3) 12.5–15.2 (3) 14.2–14.4 (3) 
Sulphate (%) 28.5–29.6 (3) 37.5–37.8 (3) 42.5–42.4 (3) 
Moisture (%) 3.2–5.2 (3) 0.4–0.5 (3) 1.7–1.9 (3) 
(1): Technical Dossier/ Supplementary Information (April 2015)/ MnGly_Composition_Company b2.pdf  
(2): Technical Dossier/ Supplementary Information (April 2015)/ MnGly_Composition_Company b4.pdf 
(3): Technical Dossier/ Supplementary Information (April 2015)/ MnGly_Composition_Company b9.pdf 
 
(a):  Three companies: b2, b4 and b9 
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Appendix D – Calculation of maximum manganese content in water for 
drinking in selected animal species  
The manganese background of complete feed for monogastric and TMR for ruminants varies generally 
between 20 and 80 mg Mn/kg, depending on the composition of the feed (Jeroch et al., 1993; van 
Paemel et al., 2010). For further calculations, 50 mg Mn/kg DM are considered as background level of 
complete feed (or of TMR) and 10 mg/kg milk replacer. On the base of the EFSA Guidance on 
tolerance and efficacy studies (EFSA FEEDAP Panel, 2011), the FEEDAP Panel derived the following 
ratios of water to feed intake: 2 for poultry, 3 for pigs and 8 for milk replacer (assuming that the 
water used for preparing the liquid feed is water for drinking). Applying these values, the following 
maximum concentrations were calculated: 50 mg Mn/L for poultry; 33 mg Mn/L for pigs and 18 mg 
Mn/L for calves. Furthermore, the EFSA Guidance (EFSA FEEDAP Panel, 2011) notes that for 
ruminants, concentrations for an additive in water for drinking cannot be consistently extrapolated 
from a fixed ratio of feed to water intake; e.g. the water intake of dairy cattle depends on milk yield, 
ambient temperature, body weight, feed dry matter content, sodium content of ration and further 
factors (Castle and Thomas, 1975; Murphy et al., 1983; Holter and Urban, 1992; Dahlborn et al., 
1998; Meyer et al., 2004) and may vary between 90 and 140 L/day for a cow with 650 kg body 
weight and producing 30 L milk/day (Meyer et al., 2004; Ward and McKague, 2007). Under 
consideration of a water intake of 8L/100 kg bw and day (Meyer et al. 2006; Ward and McKague 
2007), 30 mg Mn can be supplemented/L water. 
The maximum total daily manganese intake of dairy cows was calculated to be 3405 mg Mn/day 
based on the following assumptions: 650 kg body weight, feed intake of 22.7 kg (complete feed 
containing 88% dry matter= 20 kg DM/day (DM)) and diets contain the maximum authorised content 
(150 mg Mn/kg complete feed). The maximum manganese quantity in water for drinking is given by 
the difference between the maximum dietary manganese intake (3405 mg/day) and the manganese 
background already provided by feed materials. An expected background concentration in dairy feed 
(TMR) of 50 mg Mn/kg DM would correspond to a total intake of 1000 mg/day. Therefore, assuming 
this manganese background concentration, the maximum quantity of manganese that could be 
provided daily by water for drinking is 2405 (3405 – 1000) mg Mn/day; this daily dose complies with 
the maximum amount set for complete feed, independent from its dilution in water for drinking, which 
will obviously depend on water intake. For instance, for a cow with low or high water intake, about 27 
(at 90 L per cow and day) or 17 mg Mn/L water for drinking (at 140 L per cow and day) could be 
supplemented. The same approach can be applied for other ruminant categories, e.g. for beef cattle 
(400 kg bw, 9.09 kg feed/day= 8 kg feed DM) resulted in 960 (1364 – 400) mg Mn/day (240 mg 
Mn/100 kg bw) via water for drinking. 
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Appendix E – Manganese deposition in liver and muscle 
Table 9:  Summary of the studies provided by the applicant concerning manganese deposition in liver and muscle resulting from organic or inorganic 
manganese supplementation to animals  
Animal Manganese 
(mg/kg feed) 
Deposition in liver 
(mg Mn/kg liver) 
Deposition in muscle 
(mg Mn/kg muscle) 
Deposition in egg 
(mg Mn/kg egg yolk) 
Reference 
Total Suppl. Inorg. Organic Inorg. Organic Inorg. Organic  
Broiler 
MnSO4/ 
Mn-Prot 
n.d. 80 4.8 5.2 -                      - -                   - Bao et al., 2007 
Layer 
MnO/ 
Mn-AA 
54.7/84.7 30/60 - - -                      - 0.79/0.93    0.72/0.94 Mabe et al., 2003 
Piglet        
MnSO4/ 
Mn-Prot 
137 (inorg.) 
140 (org.) 
100 0.34 0.33 -                      - -                      - Schiavon et al., 2000 
MnSO4/ 
Mn-Prot 
19 4 3.41 3.71 0.05              0.14 -                      - Martin et al., 2011 
Dairy Cow       
MnSO4/ 
Mn-AA 
46 18 9.4 9.6 -                      - -                      - Nocek et al., 2006 
MnSO4/ 
Mn-AA 
n.d. 30 11 12 -                      - -                      - Olson et al., 1999 
Rainbow Trout       
MnSO4/ 
Mn-AA 
14 n.d. - - 2.4                 2.7 -                      - Apines et al., 2003 
MnSO4/ 
Mn-AA 
37 20 - - 1.58             1.22 -                      - Apines et al., 2004 
AA: Aminoacid; Prot: protein or hydrolysed protein; n.d.: not described 
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Annex – Executive Summary of the Evaluation Report of the European 
Union Reference Laboratory for Feed Additives on the Method(s) 
of Analysis for Manganese (E5) 
In the current application authorisation is sought under articles 4(1) and 10(2) for manganese chelate 
of glycine hydrate1, manganese chelate of amino acids hydrate1,2, manganous oxide1,3, manganous 
carbonate1, manganous chloride tetrahydrate1 and manganous sulphate monohydrate1,3 under the 
category/ functional group (3b) ‘nutritional additives’/‘compounds of trace elements’, according to the 
classification system of Annex I of Regulation (EC) No 1831/2003. Specifically, authorisation is sought 
for the use of these feed additives for all categories and species. 
According to the Applicants manganese chelate of glycine hydrate is a beige to pink free-flowing 
powder with a minimum content of 20% total manganese, manganese chelate of amino acids hydrate 
is a off-white to tan marbeled free-flowing powder with a minimum content of 10% total manganese, 
manganous oxide is a red brown-green powder with a minimum content of 59.5% total manganese, 
manganous carbonate is a beige powder with a minimum content of 44% total manganese, 
manganous chloride tetrahydrate is a pink powder with a minimum content of 27% total manganese 
and manganous sulphate monohydrate is a pink-grey crystalline powder with a minimum content of 
31% total manganese. These feed additives are intended to be mixed into premixtures, feedingstuffs 
and water*. The Applicants suggested maximum levels ranging from 100 to 150 mg total manganese 
/kg feedingstuffs and from 15 to 75 mg total manganese /L water, similar to limits set in the previous 
regulations [4,5]. 
For the characterisation of manganous sulphate monohydrate in the feed additive the EURL 
recommends the titrimetric method described in the European Pharmacopoeia monograph 1543. 
For the quantification of ‘amino acid’ content in the amino manganese chelates (i.e. manganese 
chelate of glycine hydrate and manganese chelate amino acids hydrate), the Applicant (FAD-2010-
0088) proposed the Community method based on ion exchange chromatography combined with post-
column ninhydrin derivatisation and photometric detection at 570 nm. The EURL considers the 
Community method suitable for the characterisation of the amino compounds in the frame of official 
control. 
Furthermore, the EURL identified the generic European Pharmacopoeia methods for the ‘identification 
reactions of ions and functional groups’, such as carbonate, chloride and sulphate in the feed 
additives. Finally, the EURL recommends crystallographic techniques, such as X-Ray diffraction for the 
characterisation of crystalline structures of manganous oxide, manganous chloride tetrahydrate, 
manganous carbonate and manganous sulphate monohydrate. 
For the quantification of total manganese in the feed additives, premixtures and feedingstuffs the 
Applicants submitted three ring trial validated CEN methods: EN 6869, based on atomic absorption 
spectrometry (AAS), EN 15510, based on inductively coupled plasma atomic emission spectroscopy 
(ICP-AES) and CEN/TS 15621, based on ICP-AES after pressure digestion. Precisions ranging from 2 
to 20% were reported, together with  
limits of quantification (LOQ) ranging from 1 to 5 mg/kg feedingstuffs. Furthermore, the EURL 
identified the comparative trial organised by the UK Food Standards Agency, based on the Community 
method for the determination of manganese in feedingstuffs, in which precisions ranging from 2.7 to 
7.1% were reported. 
For the quantification of total manganese in water the EURL identified the ring trial validated method 
EN ISO 11885, based on ICP-AES. The following performance characteristics are reported: - a relative 
standard deviation for repeatability (RSDr) ranging from 1.3 to 1.8%; - a relative standard deviation 
for reproducibility (RSDR) ranging from 4.6 to 6.0%; and LOQ = 1 μg/L. 
                                                          
1 FAD-2010-0088 
2 FAD-2010-0069 
3 FAD-2010-0235 
Manganese-E5 (five compounds) for all animal species 
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Based on the available performance characteristics the EURL recommends for official control all the 
above mentioned CEN methods together with the Community method to quantify total manganese 
content in the feed additives, premixtures, feedingstuffs and/or water. 
Further testing or validation of the methods to be performed through the consortium of National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
 
 
(*) for manganese chelate of glycine hydrate, manganous chloride tetrahydrate and manganous 
sulphate monohydrate (FAD-2010-0088). 
  
 
